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ABSTRACT
The Primary Care Posttraumatic Stress Disorder (PC-PTSD) screen (Prins et al., 2003) is
used by the Department of Defense to identify military members who are at increased risk of
PTSD. This screen has been offered to all returning deployers since 2005. However, validation
studies of PC-PTSD scores from military samples have seldom employed a significant number of
female subjects and no published studies have examined it for gender bias. Ruling out bias is
important because routine under-identification of PTSD risk in any group could result in
hindered access to needed assessment and/or care. With the current proportion of military
females historically high (Women’s Research & Education Institute, 2007), it is imperative that
the PC-PTSD be analyzed to ensure measurement equivalence across gender. Using a large
sample of male and female veterans returning from deployment, the validity of the PC-PTSD
scores was first examined by conducting a differential item functioning (DIF) analysis across
male and female subgroups. Then, using a clinical diagnosis as the criterion, both logistic
regression and diagnostic likelihood ratio methods were employed to assess for differential
predictive validity by gender. Finally, confirmatory factor analysis (CFA) was used to examine
convergent and divergent validity in a two-factor model containing both PC-PTSD and
depression screen responses. Results revealed no statistically significant gender-related DIF or
differential prediction of PTSD by PC-PTSD scores. Good convergent and divergent validity
were also observed in the CFA analysis. The results generally supported the continued use of the
PC-PTSD with both male and female military veterans returning from deployment. Limitations
of the study and recommendations for future research were discussed.
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CHAPTER I: INTRODUCTION
Problem and Significance
With the initiation of the Post-Deployment Health Assessment (PDHA) program during
2004, the Department of Defense (DoD) began routinely screening all military members who
were returning from Iraq and Afghanistan for posttraumatic stress disorder (PTSD). This
includes members of the US Air Force (USAF; Office of the USAF Surgeon General, 2008).
The DoD subsequently augmented this program with the Post-Deployment Health Reassessment
(PDHRA) which screens for PTSD three to six months after the return from deployment (Bliese
et al., 2008). Both of these initiatives use the same PTSD instrument: the Primary Care PTSD
screen (PC-PTSD; Prins et al., 2003). Each program was implemented to maximize early
detection of PTSD in order to increase timely access to appropriate care for affected military
members (Bliese, Wright, Adler, Thomas, & Hoge, 2007).
Recent research has indicated that military service in Iraq and Afghanistan is associated
with elevated rates of mental health problems and, specifically, PTSD. Hoge, Auchterlonie, and
Milliken (2006) reported that more than 19% of those returning from deployment to Iraq and
over 11% of those coming back from Afghanistan self-identified as having some type of mental
health difficulty. A large military cohort study (Smith et al., 2008) found that a majority of those
who were deployed in the current conflicts were exposed to combat experiences and that as
many as 8.7% of those who were exposed later received a new onset PTSD diagnosis or were
identified as having PTSD symptoms. By contrast, no more than 3% of non-deployers had a new
onset of PTSD or its symptoms.
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PTSD has been strongly associated with lifetime comorbidity with serious mental health
problems such as major depression, bipolar disorder, and substance abuse disorders in the
general population (Kessler, Sonnega, Bromet, Hughes, & Nelson, 1995). Within the military,
increased mental health problems have been related to greater attrition from service (Hoge et al.,
2006). Veterans with PTSD or trauma symptoms have demonstrated higher rates of self-reported
marital dissatisfaction and marital violence (Nelson-Goff, Crow, Reisbig, & Hamilton, 2007;
Jordan et al., 1992)
Given these problems and the elevated PTSD risk for veterans, prompt post-deployment
screening appears to provide a valuable opportunity to self-identify for helping services for those
experiencing combat-related mental health problems (Wright et al., 2007). Studies examining
trauma exposure have generally reported that males are more likely than females to report
experiencing combat (Flett, Kazantzis, Long, McDonald, and Millar, 2004; Kessler et al., 1995).
Recent casualty figures, however, may point to a narrowing of the combat exposure gender gap.
Whereas women constituted only about .01% (8 total females) of United States (US) casualties
during Vietnam (National Archives and Records Administration, 2007), that figure has increased
to 2.4% (121 total females) as of June 6, 2009, in Iraq and Afghanistan combined (Defense
Manpower Data Center, 2009a; Defense Manpower Data Center, 2009b). Considering this
casualty information along with the historically high proportion (14.3%) of US females currently
serving in the active duty military (Women’s Research & Education Institute, 2007), it is
reasonable to assume that the current counterinsurgency conflicts expose women to combat-type
trauma to a greater degree than in the past.
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There is also some evidence that PTSD manifests differently in men and women. For
instance, despite generally lower rates of exposure to trauma-inducing events (Breslau et al.,
1998; Kessler et al., 1995), women have nearly twice the risk of developing PTSD (Kessler et
al., 1995; Tolin & Foa, 2006). Several studies have indicated differences in the types of trauma
experienced by males and females. Males tend to be more frequently exposed to serious
accidents (Kessler et al., 1995; Stein, Walker, Hazen, & Forde, 1997) and, as mentioned above,
combat. Females, on the other hand, are disproportionately exposed to sexually assaultive
violence (Breslau et al., 1998; Costello, Erkanli, Fairbank, & Angold, 2002). Also, some studies
show gender differences in symptom identification on PTSD instruments (Breslau, Chilcoat,
Kessler, Peterson, & Lucia, 1999; Fullerton et al., 2001).
When considering apparent gender differences as measured by PTSD instruments, an
often implicit assumption is that any measured differences are the result of real differences in the
manifestation of the underlying PTSD trait between tested groups. An alternative explanation is
that the instrument itself is biased. This would mean that the instrument might, in this instance,
systematically show higher or lower scores for one gender despite similar levels of underlying
PTSD among males and females.
Despite the widespread employment of the PC-PTSD in screening returning combat
veterans, current validation studies for that instrument have thus far not addressed the question of
gender bias. In one study (Bliese et al., 2008), only 4% of the respondents were female and
another (Bliese, Wright, Adler, & Thomas, 2004) provided no information on the gender
breakdown of its active duty military sample. Prins and colleagues (2003) used a more gender-
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balanced sample but did not specifically assess for measurement bias. The latter researchers did,
however, find markedly lower sensitivity and specificity for women as compared to men at the
recommended cutoff level of three out of four “yes” responses.
This result suggests some potential problems associated with the differential performance
of the PC-PTSD by gender. Lower sensitivity corresponds to a higher false negative rate (given
by 1 – sensitivity), which in this instance indicates that a higher proportion of females at risk of
developing PTSD are not identified by the instrument as having that risk. Since those who are
identified as having a positive PC-PTSD result are referred for an in-person clinical evaluation
(Office of the USAF Surgeon General, 2008) this type of misidentification could lead to fewer
women receiving needed assessments. Thus, a higher proportion of women than men at risk for
PTSD would not be receiving an early opportunity for clinical care.
Lower specificity, on the other hand, results in a higher false positive rate (1 –
specificity). An elevated false positive rate for females on the PC-PTSD means that a greater
proportion of women who lack the risk for later PTSD would be erroneously identified by the
screen as being at risk. Misidentification of this type would lead to a higher proportion of
females than males being unnecessarily referred for more extensive assessment. This could
disproportionately pull women off of normal duty, and possibly, place unneeded stress on limited
military medical and mental health resources.
Given the evidence for gender PTSD differences and the wide use of the PC-PTSD with
both male and female veterans, it is important to ensure that this instrument is measuring PTSD
equivalently across genders. If measurement equivalence does not hold, direct comparison of
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scores between gender subgroups is rendered impossible since the relationship between the
PTSD construct and the observed score differs for men and women (Drasgow & Kanfer, 1985).
In the case of the PC-PTSD screen, for example, the same cut score is currently used to signal
elevated PTSD risk regardless of gender. If measurement non-equivalence is found within this
instrument, a possible implication is that one might need to use different cut scores to interpret
elevated PTSD risk when assessing females as opposed to males. Little empirical research has
been accomplished in this area with any PTSD instrument. Indeed, in a recent review of PTSD
gender differences, Kimerling, Ouimette, and Weitlauf (2007) called for further research to
examine whether PTSD assessment instruments exhibit measurement invariance with respect to
gender.
Purpose of the Study
The purpose of this study is to examine the validity of PC-PTSD scores for use in
identifying probable PTSD with both male and female military members. Initial tests will assess
measurement equivalence of the PC-PTSD across genders. This will be accomplished using item
response theory (IRT) to test for differential functioning of individual items when comparing
male and female subgroups.
Second, this study will examine the utility of the PC-PTSD for predicting a subsequent
PTSD diagnosis. This will be accomplished through use of both standard diagnostic accuracy
statistics and logistic regression modeling. Concurrent validity will be examined by relating the
PC-PTSD cutoff to the presence or absence of a clinical diagnosis of PTSD. Similarly, divergent
validity will be assessed by linking the cutoff to a diagnosis of major depression. Interactions for
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gender will be tested. Finally, the concurrent and divergent validity of the PC-PTSD will be
evaluated using confirmatory factor analysis methods.

7
CHAPTER II: LITERATURE REVIEW
As mentioned above, current evidence is that women are more likely than men to develop
PTSD. A number of potential explanations have been proposed for this disparity. These include
the neurophysiological differences between the sexes (Nemeroff et al., 2006; Saxe & Wolfe,
1999; Simmons, 2007), social factors such as gender role expectations or the social milieu during
and after the trauma (Kimerling et al., 2007; Nemeroff et al., 2006; Saxe & Wolfe, 1999;
Simmons, 2007), methodological gender bias (Kimerling et al., 2007; Simmons, 2007; Tolin &
Foa, 2006), and differing male and female exposure rates to particular types of trauma
(Kimerling et al., 2007; Nemeroff et al., 2006; Saxe & Wolfe, 1999; Simmons, 2007; Tolin &
Foa, 2006).
The proposed study will focus on the measurement aspect of possible methodological
gender bias. However, in order to provide context for the importance of this topic, the discussion
will begin with a history of the largely male-centered development of the modern diagnosis of
PTSD. This will be followed by a review of the epidemiological evidence regarding the
prevalence of PTSD among males and females and differences in both exposure to trauma and
the associated reactions to that trauma. Next, burgeoning findings on the neurobiology of PTSD
will be covered as they relate to sex differences within the diagnosis. The review will then shift
focus to gender difference evidence in PTSD symptoms. This section will provide background
directly related to the structure of the PC-PTSD: four questions assessing for the presence of
PTSD symptoms nested within one overarching query about trauma exposure and the trauma’s
initial emotional impact. Recommendations will then be presented for further research among
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the reviewed areas of knowledge, followed by a review of published validity studies on the
PTSD instrument of interest in this study, the PC-PTSD. Finally, specific research questions will
be presented.
History of PTSD
The earliest accounts of problems that are now associated with PTSD involved primarily
adult males exposed to combat. However, this was not exclusively the case. As research
gradually broadened into other groups and types of trauma, this expanded knowledge allowed the
experiences of other groups, such as women and children, to contribute to the development of the
PTSD diagnosis.
Early Conceptions
According to Rosen (1975), one of the very early descriptions of problematic reactions to
a traumatic situation came from the dissertation of a physician named Johannes Hofer in 1678.
Hofer coined the term “nostalgia” to label an illness witnessed among despairing soldiers who
had been uprooted from their homes or forced to fight in roving, illegitimate armies. Rosen
(1975) cites historical accounts which indicate that some men suffering from nostalgia eventually
became so indifferent to their circumstances that they lost interest in basic, life-sustaining
activities. Following the documentation of nostalgia, however, for nearly two hundred years the
scholarly record remained largely silent about any new conceptualizations regarding traumarelated problems. This would change with the appearance of “irritable heart” in the midnineteenth century.
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Originally reported during the United States Civil War (1861-1865) and recognized in
contemporary British soldiers of that era, irritable heart was characterized by the following
symptoms: pain in the chest, sweating, heart palpitations, fatigue, shortness of breath, and an
inability to increase one’s heart rate during physical exertion (Moore & Reger, 2007; Wooley,
2002). With the inclusion of numerous physiological reactions, irritable heart appears to have
been more closely related to the current construct of PTSD than was nostalgia. Physicians at the
time theorized that the disorder resulted from exposure to combat (Saigh & Bremner, 1999).
In the late 19th century, early psychological theories of trauma began to take shape.
Pierre Janet, while studying so-called “hysteria” with Sigmund Freud, developed the belief that
severely stressful life events could overwhelm the adaptive capacity of the mind. This could lead
to “dissociation” of the traumatic memories. Foreshadowing the current conceptualization of
PTSD as a delayed reaction, Janet theorized that these intense memories could continue to cause
problems for the sufferer long after the actual traumatic event (Flora, 2002; van der Kolk et al.,
2002). At around the same time, Kraepelin described “fright neuroses” resulting from
catastrophes such as major fires and railway accidents (Saigh & Bremner, 1999). Interestingly,
Freud’s original, published understanding of hysteria was similar to Janet’s in that intrusive
traumatic memories came from intensely stressful situations that had been compartmentalized
away from the conscious mind. He posited that hysteria was the consequence of sexual
seduction of the child by an adult. However, Freud subsequently revised his view and
supplanted this theory with one that saw hysteria as the result of childhood sexual wishes. As
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Freud’s psychoanalytic view of mental illness grew internationally in influence, Janet’s theory
about traumatic memory was gradually forgotten (Flora, 2002).
Early to Mid-Twentieth Century
While irritable heart resurfaced during World War I (1914-1918) under the revised term,
“soldier’s heart,” “shell shock” became the more overriding concern. Soldiers suffering from
shell shock were typically easily startled, agitated, complained of fatigue, had difficulty
concentrating, and exhibited mood swings. Another common presentation was the conversion
reaction, characterized by what looked like neurological loss of function in specific parts of the
body (Moore & Reger, 2007).
During the intervening years between the world wars, an important paper focused on the
plight of sexually abused children. This very early publication by Bender and Blau (1937)
described reactions such as hypervigilance, avoidance, nightmares, and reliving the trauma.
These sequelae of child sexual abuse are strikingly similar to the general constellation of PTSD
as defined in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, (DSMIV; American Psychiatric Association, 1994; Saigh & Bremner, 1999).
In the Second World War (1939-1945), military medical personnel commonly used the
term “battle fatigue” to describe a syndrome similar to that denoted by shell shock. Although
sharing similar symptoms with shell shock such as loss of function, anxiety, difficulty
concentrating, and fatigue, battle fatigue also often involved depression, lack of motivation, and
memory loss (Moore & Reger, 2007). Since the United States (US) Army continues to use the
term “battle fatigue” in connection with combat stress today, a crucial distinction must be made:
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Battle fatigue and PTSD are not identical (Moore & Reger, 2007). By definition, PTSD is a
delayed stress reaction while battle fatigue need not be so. However, battle fatigue shares much
in common with the modern diagnosis of acute stress disorder (ASD) which has been shown to
be strongly associated with later development of PTSD (Kutz & Dekel, 2006).
The progression toward the modern conceptualization of PTSD continued during and
after World War II with widespread treatment of veterans suffering from “combat-” or “war
neuroses” (Flora, 2002; Saigh & Bremner, 1999). Kardiner (1941) published a work that has
been recognized as one of the first characterizations of war neurosis that resembles PTSD (Flora,
2002; van der Kolk et al., 2002). He described a physiological component of hyperarousal and
proposed that the individual was behaving as though the threat of the trauma remained present
(van der Kolk et al., 2002). Kardiner also identified chronic problems with irritability, being
easily startled, reduced interest, and a pattern of dreaming that was typical of war neurosis
(Flora, 2002).
First Diagnosis to Modern PTSD
In the post-World War II years, the scale of the numbers of former soldiers suffering
from war neuroses coupled with mounting information on the psychological effects of exposure
to concentration camps and prisoner of war camps led the American Psychiatric Association
(APA) to develop a new category for these problems (Saigh & Bremner, 1999). The DSM-I
(1952) introduced “gross stress reaction.” Although the APA did not provide specific criteria to
be met for such a diagnosis, it acknowledged the severe mental distress that could result in
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otherwise normal individuals who had been exposed to stressors such as warfare or serious
catastrophe.
The Korean conflict of the 1950’s provided further evidence of the PTSD-like symptoms
exhibited by many veterans exposed to combat. This time period and the subsequent 1960’s
were especially significant, however, for the surge in research regarding trauma suffered during
civilian accidents and disasters. Interestingly, due to the Cold War much of this work on the
psychological and physiological effects of floods, earthquakes, and manmade tragedies was
pursued and funded in an effort to better understand the mental consequences of a nuclear attack
on a populace (Saigh & Bremner, 1999). In the end, such civilian disaster studies largely
confirmed reactions such as avoidance, irritability, nightmares, and reexperiencing that had
become familiar to combat trauma researchers and clinicians.
Later in the 1960’s and into the 1970’s, Vietnam veterans began to return—many
suffering from persistent problems with war trauma. However, the diagnosis of problems related
to traumatic events remained difficult due to a continuing lack of diagnostic criteria specific to
this clinical issue in the new DSM-II (American Psychiatric Association, 1968; Flora, 2002).
Instead, the diagnosis currently recognized as PTSD was increasingly unofficially recognized
and discussed as a result of the large number of troubled veterans seeking treatment for similar
problems at the nation’s VA hospitals (Flora, 2002; Saigh & Bremner, 1999).
Around the same time, several researchers finally began to examine women’s reactions to
traumatic events on a significant scale by turning their attention to the effects of sexual assault.
Burgess and Holmstrom (1974) studied women who were rape victims and identified a longer-
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term phase of their “rape trauma syndrome” that included fear, avoidance, sexual problems, and
aversive thoughts and dreams related to the assault. Other researchers began investigating
females’ reactions to rape and again reported a symptom pattern similar to that found in other
types of trauma (Saigh & Bremner, 1999). Thus, sexual assault was added to a growing list of
seemingly disparate traumatic events that each appeared strongly linked to a relatively uniform
symptom pattern.
Finally, after the “social epidemic” (Moore & Reger, 2007, p. 165) of troubled Vietnam
veterans, PTSD was formally recognized in 1980’s DSM-III (American Psychiatric Association).
It had become evident to many experts in the burgeoning field of trauma that widely varied
events could produce a similar constellation of symptoms across diverse populations. The term
PTSD now united the various unique labels previously associated with particular types of
trauma. The DSM-III also contained specific diagnostic criteria divided into four categories:
extremely stressful event, reexperiencing symptoms, numbing symptoms, and a category
containing mostly physiological symptoms. While there have been important changes to these
criteria in subsequent DSM editions and revisions, these broad categories of diagnostic criteria
remain largely intact (Saigh & Bremner, 1999).
This historical review demonstrates that the impetus for the development of our current
PTSD diagnosis was primarily rooted in concern over males suffering symptoms subsequent to
combat exposure. While research into the effects of trauma other than combat and experienced
by groups besides adult males was initially less voluminous, such knowledge eventually
influenced the debate over the PTSD diagnosis in a significant way. In fact, as noted above,
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researchers largely recognized that the symptoms represented in PTSD applied to a wide range of
traumatic experiences and populations. Indeed, an analysis of data for the DSM-IV field trials
(Kilpatrick, Resnick, Saunders, & Best, 1998) revealed no significant differences in the way
males and females with PTSD responded to individual PTSD symptoms on the Structured
Clinical Interview for DSM-IV (Spitzer, Williams, Gibbon, & First, 1995).
Shortly after PTSD’s acceptance as a legitimate diagnosis, work began to establish the
prevalence of this new disorder in various populations. The discussion now turns to a review of
the epidemiology of PTSD from the perspective of gender.
Gender Differences in PTSD
Epidemiological studies provide the basis for the first two parts of this section: gender
differences in PTSD prevalence and exposure rates to potentially traumatizing events. Next,
male/female differences in the immediate emotional reactions to trauma exposure will be
examined. The section will conclude with coverage of research into differential patterns of
PTSD symptom reporting among males and females.
Higher Female PTSD Risk and Prevalence
Several epidemiological studies have reported elevated PTSD rates among women.
Notable are those studies using probability sampling methods to attain large, representative
samples and assessed with a standardized structured diagnostic interview. Among these, the
results from the National Comorbidity Study (Kessler et al., 1995) are frequently cited. This
report stated that lifetime PTSD prevalence was 10.4% for women and 5.0% for men. Helzer,
Robins, and McEvoy (1987) discovered much lower lifetime prevalence levels in the
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Epidemiologic Catchment Area Survey, but again females’ PTSD rates (.13%) were more than
twice as high as that observed with males (.5%).
Similar findings emerged when researchers assessed for lifetime prevalence only for
those exposed to at least one traumatizing event. Kessler and colleagues (1995) analyzed a
subset of their sample who had experienced at least one such event and found that traumaexposed females were significantly more likely to have PTSD than trauma-exposed males (odds
ratio = 6.13, p < .05). Using similar methodology among young adults in the Detroit, MI,
vicinity, Breslau et al. (1998) reported the prevalence of PTSD after trauma at 13.0% for females
and 6.2% for males.
The pattern of higher female PTSD rates has largely held within international
populations, as well. Recent epidemiological work in Mexico (Norris et al., 2003) revealed that
females’ PTSD lifetime prevalence was also about twice that of males (15% for women, 7% for
men). Peters, Issakidis, Slade, and Andrews (2006) assessed the twelve-month prevalence of
PTSD among Australian adults. They also discovered a nearly 2:1 ratio of female to male PTSD
(4.2% and 2.3%, respectively).
A couple of Canadian studies (Stein, Walker, & Forde, 2000; Stein et al., 1997), using a
PTSD self-report instrument instead of structured interviews, found elevated risk for women.
Results of Stein et al. (1997) indicated that women were significantly more likely than men to
currently have both full PTSD (5.0% vs. 1.7%, respectively) and partial PTSD (5.7% vs. 2.2%).
In Stein and colleagues (2000), 8.2% of women versus 1.8% of men were judged by the
instrument to have either partial or full PTSD. This difference constituted an odds ratio (OR) of
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4.79, meaning that the odds of having full or partial PTSD were almost five times higher for
women than for men. In both Canadian studies, partial PTSD meant not meeting the full
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV; American
Psychiatric Association, 1994) criteria, but having at least one symptom in each required
symptom category.
Similar results have been observed when the focus shifts to youth. The final report from
the National Survey of Adolescents (Kilpatrick and Saunders, 1997) indicated sex differences in
prevalence levels for both current PTSD (6.2% for girls, 3.7% for boys) and lifetime PTSD
(10.1% and 6.2%, respectively). Also, Breslau, Davis, Andreski, Peterson, and Schultz (1997)
found that when they analyzed a subset of their sample who had experienced an initial trauma
when they were fifteen or younger, there was a marked disparity between female and male PTSD
risk (hazards ratio = 11.4). Costello et al. (1996), on the other hand, failed to find a significant
difference in a general population sample of children.
The evidence is somewhat ambiguous, however, with large studies of military samples.
In the report on the congressionally-mandated National Vietnam Veterans Readjustment Study,
Kulka et al. (1990) indicated that men, not women, had a much higher prevalence of current
PTSD. In fact, in this case the male prevalence (15.2%) was nearly twice that of females (8.5%).
The National Vietnam Veterans Readjustment Study used a probability sample of 1200 men and
women who had served in Vietnam at some time between 1964 and 1975 (women and some
minorities were oversampled). PTSD was assessed using the Mississippi Scale for CombatRelated PTSD (Keane, Caddell, & Taylor, 1988).
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Turner, Turse, and Dohrenwend (2007) recently reanalyzed the National Vietnam
Veterans Readjustment Study data to investigate possible explanations for the prevalence
findings in this sample that are so contradictory to the results of most comparable civilian
studies. Two relevant findings emerged: First, they found that when they controlled for the prewar PTSD risk factors minority status, education level, and age, the prevalence difference (while
not statistically significant) actually changed directions, with female Vietnam veterans at 4%
higher prevalence than male veterans with the lowest combat exposure. Second, when the
researchers endeavored to compare males and females with similar degrees of exposure to both
medical trauma and combat trauma, no gender-related difference in PTSD prevalence was found.
More recently, Smith and colleagues (2008) analyzed a very large (N = 50,184; 27.6%
female) population-based, US military sample from the prospective millennium cohort study.
Although the final sample was not random, it included active duty members from all the
services, as well as members of the reserves and national guard—none of whom had been
deployed to Iraq or Afghanistan prior to joining the larger study. After being sampled for Smith
et al. (2008), 23.8% of the participants deployed to Iraq or Afghanistan (26.8% of men, 16.1% of
women) during the study period.
The researchers reported that among those subjects with no PTSD symptoms or diagnosis
at baseline, 4.7% of females and 3.1% of males experienced a new PTSD diagnosis or were
positive for PTSD symptoms within the previous three years as measured by sensitivitymaximizing criteria of the PTSD checklist (PCL; Blanchard, Jones-Alexander, Buckley, &
Forneris, 1996). Using criteria from the same instrument that instead maximized specificity
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yielded similar results, with PTSD prevalence at 3.8% for women and 2.4% for males. The
authors also looked at new onset PTSD (judged using the specific PCL criteria or PTSD
diagnosis) by gender for each service. All services but the Marines had a significant OR,
indicating that females were significantly more likely to be classified as having new onset PTSD.
Of interest for the current study are the results for the Air Force: New onset PTSD was judged in
1.0% of males and 2.0% of females (OR = 2.00, 95% confidence interval: 1.41 to 2.83).
Indeed, two meta-analytic studies (Brewin, Andrews, & Valentine, 2000b; Tolin & Foa,
2006) on the subject have confirmed women’s higher risk for PTSD. Both meta-analyses
assessed a mix of veteran and civilian samples. The analysis by Brewin and colleagues (2000b)
indicated a relatively small, but significant effect size for gender on PTSD (r = .13, p < .001).
Tolin & Foa’s (2006) work revealed a stronger mean effect (OR = 1.98, p < .001; meaning
females had nearly twice the odds of PTSD than men) across all independent samples. In fact,
they found that when the gender effect was compared between variables related to
methodological differences (e.g., lifetime or current PTSD, interview or questionnaire,
epidemiological or convenience sample), none of the methodological factors resulted in a
significant change to the effect size indicating women’s greater PTSD risk.
It appears that the evidence points to increased risk of PTSD for women when compared
to men. Although there is some ambiguity on this among US military and veteran samples,
recent work has tended to support the differential seen in the more numerous, epidemiologicallybased civilian studies. The discussion will now turn to gender differences in exposure to
traumatic events.
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Trauma Exposure Differences
As noted above, evidence indicates that females have somewhat lower exposure to
potentially traumatic events (PTEs) despite their comparatively higher risk for PTSD. Some of
the epidemiological studies mentioned previously have examined this issue. Kessler et al.
(1995), Norris et al. (2003), and Stein et al. (1997) all found that a significantly higher
percentage of males than females reported experiencing at least one PTE during their lifetime. In
the National Comorbidity Study (Kessler et al., 1995) these figures were 60.7% for males and
51.2% for females. Two probability-sampled epidemiological studies using the liberalized
DSM-IV criterion for a qualifying event indicated somewhat higher PTE prevalence: Stein and
colleagues (1997) reported male lifetime exposure at 81.3% compared to 74.2% for females, and
Norris et al. (2003) more recently found comparable figures at 83% and 71% for men and
women, respectively.
On average, men also tend to report a higher number of lifetime PTEs than women.
Breslau et al. (1998) found that males endorsed an average of 5.3 lifetime traumatic events,
compared to 4.3 among females. The averages reported by Norris et al. (2003) were lower (2.6
events for men, 1.7 events for women), but the difference was likewise significant. However,
given the unique characteristics of various trauma categories, these overall PTE figures are very
gross measures of trauma exposure level. Therefore, the remainder of this section will focus on
the research into differential gender exposure to specific types of PTE.
The one large epidemiological study using a representative probability sample of the
entire United States (Kessler et al., 1995) reported that males were significantly more likely than
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females to identify themselves as experiencing PTE such as combat (6.4% vs. 0.0%,
respectively), physical attack (11.1% vs. 6.9%), life-threatening accident (25.0% vs. 13.8%),
being personally threatened with a weapon (19.0% vs. 6.8%), and witnessing a serious injury or
killing (35.6% vs. 14.5%). On the other hand, females more frequently endorsed rape (9.2% of
females vs. 0.7% of males), being sexually molested (12.3% vs. 2.8%), childhood physical abuse
(4.8% vs. 3.2%), and parental neglect (3.4% vs. 2.1%).
The Breslau et al. (1998) study of a Detroit-area random sample revealed a similar
pattern of differences: Men exhibited heightened risk of exposure to assaultive violence other
than rape, such as being physically beaten up (males = 13.1%, females = 9.8%), being either shot
or stabbed (males = 8.2%, females = 1.8%), and being threatened with a weapon or mugged
(males = 34.0%, females = 16.4%). Women were more at risk for rape (females = 9.4%, males =
1.1%) and other types of sexual assault (females = 9.4%, males = 1.8%). An analysis of the
Great Smoky Mountains Study (N = 1420) of randomly selected children and adolescents by
Costello and colleagues (2002) revealed that boys were significantly more likely to have a
lifetime history of violent physical victimization by a non-family member (0.8% of boys,
compared to 0.4% for girls) and causing death or serious harm to others (0.2% of boys,
compared to less than 0.1% for girls). Girls exhibited heightened incidence of rape (0.4% of
girls, compared to less than 0.01% for boys), sexual abuse (3.4% of girls, compared to 1.8% for
boys), and violent physical victimization by a family member (1.2% of girls, compared to 0.5%
for boys).
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These epidemiological PTE exposure differences mirror findings from outside of the
United States, as well. In Mexico (Norris et al., 2003), females were again shown to be more
likely than males to identify a history of sexual assault (3.9% vs. 1.1% for women and men,
respectively). Males, on the other hand, were disproportionately exposed to combat (3.2% for
men vs. 1.1% for women), acts of terror or torture (1.1% vs. 0.3%), being physically assaulted
(27.8% vs. 13.5%), experiencing an accident that threatens life (45.1% vs. 21.9%), being
threatened with a weapon (28.3% vs. 8.3%), and witnessing someone else being seriously injured
or killed (45.6% vs. 26.3%). Stein and colleagues’ (1997) Canadian sample showed a similar
pattern. Men more often experienced combat, severe MVAs, being personally threatened with a
weapon, and witnessing someone else’s serious injury or death, but women more frequently
endorsed experiencing rape and sexual molestation (all reported as significant, although no
specific statistics provided).
A couple of studies have examined trauma exposure with convenience samples
containing at least a substantial proportion of individuals affiliated with the military. Bolton,
Litz, Britt, Adler, and Roemer (2001) surveyed a highly male (90%) convenience sample of 2947
(mean age = 26) US Army personnel about to deploy to Bosnia-Herzegovina for peacekeeping
duty. Once more, females more often reported sexual assault than males (27% and 5%,
respectively) and males more often reported witnessing an event involving someone else’s
serious injury or illness (53% of males, 46% of females). However, the researchers used an
unstandardized self-report instrument created specifically for this study which used a smaller
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number of broad PTE categories (5) compared to most studies that have investigated this issue
(typically, 10+ categories of PTE that are more specific in scope).
Using the Trauma Event Questionnaire (Vrana & Lauterbach, 1994) to assess PTE, Amir
and Sol (1999) assessed for trauma in a non-random undergraduate sample within which 17.5%
of the females and 23.8% of the males had previously served as Israeli army officers. Women
were more exposed to rape and sexual assault (combined: 10% of females vs. 1% of males),
while men were more exposed to civilian MVAs (34% of men vs. 27% of women) and militaryrelated trauma connected to the Intifada (42% of men vs. 3% of women), the war in Lebanon
(5% of men vs. 1% of women), terror attacks while in the military (23% of men vs. 3% of
women), and other military operations (45% of men vs. 3% of women). It was not clear from the
article what types of jobs the subjects held while in the military.
To sum up, the weight of the evidence for differential exposure to trauma indicates that
women more frequently report sexual trauma such as rape and sexual assault, while men more
frequently endorse a history of experiencing combat, accidents, and non-sexual violence. The
meta-analysis by Tolin and Foa (2006) confirmed this pattern with the greatest significant
differences in adult sexual assault, child sexual abuse, and a category including combat, war, and
terrorism experiences. It is tempting to ascribe females’ higher incidence of PTSD to these wellsupported PTE differences. However, the same meta-analysis (Tolin & Foa, 2006) revealed that
the PTSD gender disparity persisted even after controlling for the type of exposure that was
experienced. The discussion now turns to neurobiological issues related to gender and PTSD.
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Neurophysiology and the PTSD Gender Difference
Researchers’ knowledge of the body’s stress response has grown dramatically over the
last decade. This section will begin with a summary of some major physiological aspects of
stress and PTSD. Then, gender differences with regard to these physiological processes will be
explored. Finally, the discussion will turn to how such differences may affect one’s vulnerability
to stress disorders later in life.
Hypothalamic-Pituitary-Adrenal (HPA) Axis
Overview of the HPA axis. Among the most heavily investigated biological
mechanisms associated with PTSD and other stress responses is the HPA axis. This system is
comprised of the hypothalamus, the pituitary gland, and the adrenal glands. Under normal
circumstances these three structures act as a feedback loop to regulate the body’s release of
cortisol and other glucocorticoids that, in turn, help the body prepare to deal with stress. Among
other functions, cortisol facilitates use of the body’s energy stores, enhances attention and the
encoding of memory, and curbs the sympathetic stress reaction by serving as an “antistress”
(Yehuda, 2001, p. 41) hormone (Charney, 2004; Rasmusson & Friedman, 2002; Yehuda, 2009).
The cascade begins when neurotransmitters from other parts of the brain signal the
hypothalamus to increase its release of corticotrophin-releasing factor (CRF). When the pituitary
gland receives CRF, it is stimulated to secrete adrenocorticotropic hormone (ACTH) into the
bloodstream. Circulation then transports ACTH to the adrenal gland where its arrival causes the
adrenals to release glucocorticoids, including cortisol, into the blood. Negative feedback is
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accomplished in the loop when glucocorticoids binding to glucocorticoid receptors in the
hypothalamus and hippocampus exert an inhibitory effect on further CRF secretion.
Ideally, the balance achieved in this system allows the body to adequately prepare for a
threat while minimizing the detrimental physiological effects of chronically high levels of
cortisol and other glucocorticoids (Charney, 2004; Meyer & Quenzer, 2005). However, the HPA
system may not immediately return to normal, baseline levels despite cortisol’s negative
feedback inhibition. This breakdown, in part, may result when the amygdala perceives the
presence of a threat and consequently continues sending signals to stimulate HPA activity. But
once the stressor is no longer detected and the amygdala ceases its excitatory signaling, the
glucocorticoids can have their full inhibitory effect on the HPA and the hippocampus to rein in
the body’s stress response (Yehuda, 2001).
PTSD and the HPA axis. PTSD has been associated with alterations in HPA
functioning. However, with regard to cortisol, there is disagreement as to the direction of this
association (Johnson, Delahanty, & Pinna, 2008). Some studies have reported that individuals
with PTSD tend to have lower levels of cortisol (e.g., Bremner, Vermetten, & Kelley, 2007; Gill,
Vythilingam, & Page, 2008; Kanter et al., 2001; Yehuda, Boisoneau, Lowy, & Giller, 1995;
Yehuda, Boisoneau, Mason, & Giller, 1993; Yehuda, Teicher, Trestman, Levengood, & Siever,
1996). Others (e.g., Lemieux & Coe, 1995; Pitman & Orr, 1990; Rasmusson et al., 2001) instead
found that cortisol levels for those with PTSD were higher than for controls. Still others have
found no significant association between PTSD and cortisol (Young & Breslau, 2004a, 2004b) or
a very small negative relationship despite a large sample size (Boscarino, 1996).
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Several possible explanations have been suggested for these disparate findings, including
characteristics of the trauma (e.g., severity, frequency, and time elapsed since the trauma),
comorbidity, sex, menopausal factors for females (Johnson et al., 2008), and smoking status
(Rasmusson et al., 2001). Others have focused on the diverse methods used to measure cortisol.
The 24-hour urinary free cortisol test has been criticized for missing brief, periodic changes in
cortisol levels that are associated with circadian rhythms (Yehuda, 2009). On the other hand,
methodologies utilizing plasma cortisol levels obtained by extracting blood samples every 30-60
minutes during a twenty-four hour period (e.g., Yehuda et al., 1996) are subject to the criticism
that being hospitalized or removed from daily life itself could alter the subjects’ cortisol levels
due to changes in their perceived stress (Rasmusson et al., 2001). Salivary cortisol levels have
the advantages of being less invasive and easily performed in a more naturalistic stress setting
such as at home (Young & Breslau, 2004b). However, unless the timing of the sampling is
adequately controlled they may obscure cortisol differences that tend to only depart from normal
levels at certain times of the day (Yehuda, 2009).
Possible mechanisms for the HPA axis role in PTSD. Competing arguments have been
made as to what conclusions can be drawn from these seemingly divergent findings on the
relationship between PTSD and cortisol levels. Rasmusson, Vythilingam, and Morgan (2003)
posit that the case is stronger for an upregulation of HPA activity that results in hypercortisolism.
They point out that in many of the studies connecting lower cortisol with PTSD that used urinary
cortisol measures (e.g., Yehuda et al., 1993; Yehuda et al., 1995), subjects were confined to
either a hospital or home setting which could have resulted in lower stress and thus lower cortisol
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levels. Indeed, these authors present a number of reports (e.g., Lemieux & Coe, 1995; Pitman &
Orr, 1990; Rasmusson et al., 2001) as evidence that studies using similar cortisol measurement
techniques with individuals maintaining more normal, non-sequestered daily routines have
typically resulted in higher cortisol for those with PTSD. Further, they point out that such
hypercortisolism is consistent with studies that report elevated CRF levels among those with
PTSD (e.g., Baker et al., 1999).
Yehuda (2001, 2009) alternatively argues that some of the studies indicating higher
cortisol suffered from problems measuring cortisol that call their results into question. She
asserts that the majority of studies that used frequent, regular measures of cortisol throughout the
day were better at capturing the rhythmic nature of cortisol excretion—and that such
investigations tended to show a pattern of lower cortisol in conjunction with PTSD when
compared to controls. This researcher reconciles the elevated CRF findings with those revealing
lower cortisol levels by citing evidence that glucocorticoid receptors are sensitized in PTSD
(Yehuda et al., 1995), which she hypothesizes would result in stronger negative feedback in the
HPA system.
Many studies using the dexamethasone suppression test (DST) appear to support this
hypothesis (e.g., Yehuda et al, 1993; Yehuda et al., 1995; Griffin, Resick, & Yehuda, 2005). In
DST, a small dose of dexamethasone (a synthetically-produced substance with pharmacological
action that is very similar to cortisol) is administered in order to test the extent to which
endogenous cortisol is affected (Yehuda, 2001). Following DST, studies with various PTSD
populations have reported resulting cortisol to be lower than controls—which is consistent with
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sensitized glucocorticoid receptors enhancing the negative feedback inhibition of the HPA
system.
It appears the bulk of the evidence indicates that PTSD is associated with some form of
cortisol dysregulation within the HPA axis. However, until more well-controlled studies with
uniform cortisol measurement methods are employed and replicated with similar results, the
exact nature of this dysregulation will remain debatable. The discussion now turns to another
neurochemical involved in the body’s stress response: norepinephrine.
Norepinephrine
Overview of norepinephrine. Norepinephrine (NE) is a catecholamine that has been
associated with arousal via the locus coeruleus (LC), memory of stressful events through the
amygdala, and cognition through its involvement in the prefrontal cortex (PFC) (Charney, 2004;
Southwick, Rasmusson, Barron, & Arnsten, 2005). Specifically, stress activates NE in the LC
(Charney, 2004), which contributes to stimulation of the sympathetic nervous system and the
enhancement of vigilance (Southwick et al., 1999). In turn, activated NE connections between
the LC and the amygdala appear to facilitate enhanced consolidation of memories associated
with the acute stress (Charney, 2004). The amygdala also sends signals on to the PFC, among
other structures. Under these stressful circumstances, elevated NE interferes with PFC functions.
This results in a diminishing of higher cognition (Charney, 2004; Southwick et al., 1999).
PTSD and NE. Clinical studies of combat veterans (Kosten, Mason, Giller, Ostroff, &
Harkness, 1987; Yehuda et al., 1998) and victims of child sexual abuse (De Bellis, Baum,
Birmaher, & Ryan, 1997; Lemieux & Coe, 1995) have generally shown that subjects with PTSD
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have significantly elevated baseline NE when compared to controls. Others have stimulated NE
release by administering yohimbine, an antagonist of the α2 adrenergic receptors which are
autoreceptors on noradrenergic neurons. Both Southwick and colleagues (1993) and Bremner et
al. (1997a) found that administration of yohimbine resulted in most (70% and 60% in each study,
respectively) PTSD subjects experiencing panic attacks and a substantial portion experiencing
flashbacks (40% and 30%, respectively). This contrasted with no panic attacks among controls
in either study, zero flashbacks in the Bremner et al. (1997a) control group, and only one
flashback among controls in the Southwick et al. (1993) study. The latter study (Southwick et
al., 1993) also reported a significant post-yohimbine increase in symptoms related to PTSD for
those with PTSD compared to controls. These results appear to also lend support to the case for
hyper-release of NE among those with PTSD.
Possible mechanisms for NE’s role in PTSD. Indications are that increased NE would
enhance fear-related arousal and attention mediated by the LC due to NE’s stimulating effect on
that structure. A relatively high level of NE also tends to aid in the encoding of fearful or
stressful memories through the amygdala (Southwick et al., 2005). A recent study (van Stegeren
et al., 2005) using functional magnetic resonance imaging (fMRI) and blocking NE activity with
propranolol provided some support for NE’s role in mediating amygdala activity related to
memory formation. Those receiving placebo (and therefore experiencing a relatively normal NE
level) during exposure to stress-provoking visual images showed significantly greater amygdala
activation than subjects receiving propranolol. When memory was tested at two weeks, the
placebo also resulted in a larger difference between the memory of stressful vs. non-stressful
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images when compared to the propranolol condition. This implies that the effect of the
propranolol’s blocking of NE activity was to inhibit the normal, enhanced memory formation for
the stressful images.
Also, a couple of clinical studies (Yehuda, Southwick, Giller, Xiaowan, & Mason, 1992;
Lemieux & Coe, 1995) have explicitly linked elevated NE to increased endorsement of intrusive
memories on the Impact of Events Scale (IES; Horowitz, Wilner, & Alvarez, 1979). One
hypothesis for this result is that high levels of catecholamines such as NE contribute to the
intrusion of these traumatic memories by their interference with the PFC. This interference
might reduce the capacity of the PFC to inhibit such thoughts (Southwick et al., 1999).
Neuropeptide Y
Overview of neuropeptide Y. Neuropeptide Y (NPY) is an amino acid peptide
commonly found throughout the mammalian nervous system. Although it has not been studied
as extensively as the catecholamines or the neurochemicals directly related to the HPA axis,
evidence suggests that it does play an important role in the human stress response. NPY is
secreted in conjunction with high-level activation of the sympathetic nervous system
(Rasmusson & Friedman, 2002), may be involved with inhibiting the consolidation of fear
memories through both the amygdala and hippocampus, and appears to provide an anti-anxiety
balance to CRF in the body’s stress response system via the LC and the amygdala (Charney,
2004).
Some initial evidence seems to indicate that this neurotransmitter also aids in the adaptive
management of extreme stress levels. Morgan and colleagues (2000) studied hormone levels
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among a group of soldiers participating in an intense survival training meant to approximate
many types of wartime stress. The researchers reported positive correlations between NPY
levels and successful behavioral performance under stress. Results also revealed negative
associations between NPY and dissociative symptoms.
PTSD, NPY, and possible mechanisms. NPY has been shown to be low among
subjects with PTSD (Rasmusson et al., 2000). Further, there are indications that a deficit of NPY
may be linked with other conditions that have been associated with PTSD. For instance, sleep
disturbance is a common comorbid problem with PTSD (Mellman, 1997) and in animal models
NPY has been shown to interact with glutamate to affect circadian phase shifts in sleep (Biello,
Golombek, & Harrington, 1997). Another animal study (Greber, Schwarzer, & Sperk, 1994)
indicated NPY inhibits the release of glutamate, another neurotransmitter which has been
implicated as a contributing factor in stress-related atrophy of the hippocampus (McEwen, 2000).
When taken together with research that has associated PTSD with smaller hippocampal volume
(Bremner et al., 1997b), this suggests the possibility that low NPY may contribute to PTSDrelated reductions in the volume of the hippocampus. However, research has yet to explicitly
confirm this hypothesized connection.
Gender Differences Related to the HPA Axis, NE, and NPY
Historically, research into the neurobiology of PTSD and stress has focused on males
(Andreano, Arjomandi, & Cahill, 2008; Rasmusson & Friedman, 2002). This has begun to
change in recent years, though, with increasing investigation of the role that female sex
hormones and the menstrual cycle play in modifying the body’s stress hormone response. The
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early evidence indicates that these female-specific biological systems may interact with the HPA
axis, NE, and NPY in PTSD.
HPA axis-related gender differences. A few studies have focused on estrogen and its
relationship to hormones in the HPA system. In both a study of female animals (Young,
Altemus, Parkison, & Shastry, 2001) and a small (N = 12) study of perimenopausal women
(Komesaroff, Esler, & Sudhir, 1999), indications were that administering exogenous estrogen
reduced ACTH and thereby cortisol under conditions of stress. On the other hand, an
investigation of nine women (age range: 44-48) undergoing ovariectomies (De Leo, la Marca,
Talluri, D’Antona, & Morgante, 1998) also showed reduced ACTH even though estrogen was
very low post-surgery. However, in this study all subjects received the surgery and subsequent
hormone testing, whereas Komesaroff et al. (1999) randomized assignment to treatment or
placebo conditions. Cucinelli and colleagues (2002), although not focusing on PTSD or the
stress response specifically, also found that administration of estrogen was associated with a
significant ACTH decrease, this time in 20 postmenopausal women. Possible mechanisms for
estrogen’s effects on ACTH include changes to glucocorticoid negative feedback or alterations in
the overall stimulation of the entire HPA axis (Charney, 2004).
Menstrual cycle and the HPA axis. More recently, studies have begun to compare
different phases of the menstrual cycle in an attempt to elucidate the interactions between stress
response hormones and female sex hormones. Goldstein et al. (2005) measured skin and brain
arousal (using fMRI) in response to negative visual stimuli among twelve premenopausal women
during both the early and late follicular phases of the menstrual cycle. Estrogen was higher in
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the late follicular phase, which coincided with attenuation in both skin arousal and arousal in
brain structures related to HPA function. Although there was no separate comparison group, the
results support a role for estrogen in destimulating the HPA axis.
Other studies have investigated hormonal changes and stress-related memory. Andreano
and colleagues (2008) looked at salivary cortisol and long-term memory across three distinct
phases of the menstrual cycle. The study involved 64 women experiencing normal, natural
cycling, alternatively exposed to warm water (control/neutral stress) or ice water (cold-pressor
stress) immediately after reading a narrative passage. One week later the subjects were tested on
their recall of the passage. The authors reported a positive relationship between cortisol levels
and ability to recall for those originally exposed to the water conditions during the mid-luteal
phase—when both estrogen and progesterone are elevated. Those subjects presenting during the
early or late follicular phases showed no such correlation. This result is consistent with research
showing that cortisol generally enhances memory consolidation (e.g., Abercrombie, Kalin,
Thurow, Rosenkranz, & Davidson, 2003) and it informs studies reporting that the effect of
cortisol on memory differs for men and women (Andreano & Cahill, 2006; Jackson, Payne,
Nadel, & Jacobs, 2005). Neither of these reports showing differential gender effects on memory
for glucocorticoids (Andreano and Cahill, 2006; Jackson et al., 2005) controlled for the phase of
menstrual cycle among the female subjects. In light of the Andreano et al. (2008) study, it
appears that cyclical fluctuations in gonadal hormones such as estrogen could have led to the
reported gender differences in the effects of cortisol on memory. This suggests a role for sex
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hormones in modulating the nature of women’s HPA stress response—at least with respect to
memory.
Fear conditioning. The precise mechanism for how the neurobiology of memory is
involved in PTSD remains under investigation. However, classical fear conditioning has been
proposed as one plausible method whereby memory might be connected to PTSD and other
anxiety disorders (Charney, 2004; Garakani, Mathew, & Charney, 2006). Fear conditioning is
theorized to involve memory-related structures such as the amygdala (numerous proposed
functions, including fear acquisition and associating the unconditioned stimulus [UCS] with the
conditioned stimulus [CS]), the prefrontal cortex (long-term, extinction-related memory), and the
hippocampus (consolidation of fear-related memories into long-term memory) (Charney,
2004)—all of which appear to be functionally affected by cortisol (Rasmusson et al., 2001).
Milad and colleagues (2006) recently investigated whether fear conditioning itself was
affected by the menstrual cycle. They studied 42 subjects (66.7% female) randomly assigned to
two conditioning contexts where visual stimuli (the CS) were first paired with a mild (nonpainful) electrical shock (the UCS) and then extinguished over a period of two days. Retention
of the extinguishment memory was measured by skin conductance when the subjects were
exposed to the CS on the second day. The researchers reported that among women in the late
follicular phase of their cycle, when estrogen levels are elevated relative to the early follicular
phase, retention of the extinction learning was at a significantly lower level compared to men and
to women in the early follicular phase. This finding is important, because problems with
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successful extinction can result in ongoing problems with anxiety (Garakani et al., 2006), such as
is observed with PTSD and other anxiety disorders.
None of these studies were conducted with subjects diagnosed with PTSD, so any explicit
role for sex hormones in mediating the HPA response within this disorder remains to be
discovered. However, the evidence for estrogen’s effects on the HPA system in healthy subjects
and its impact on memory indicate that, in light of the gender differences in PTSD, further
research into the interactions among these factors is warranted.
Gender differences in the NE system. A few studies have examined gender differences
in NE. Luine (2002) found that when female and male rats were exposed to identical regimens
of chronic, repeated restraint stress, only female rats exhibited higher levels of NE in the
hippocampus. Conversely, two human studies reported elevated NE among males.
Frankenhaeuser et al. (1978) compared male (N = 19) and female (N = 30) high school students
exposed to either a normal (typically non-stressful) or a stressful academic situation. The
analysis revealed that in the stress condition males consistently excreted higher levels of urinary
NE than females. More recently, a study of 315 (65% female) healthy nursing students
randomly selected from a volunteer pool (Deane, Chummun, & Prashad, 2002) also found
elevated NE among males. The authors assert that the male and female subsamples were
homogeneous on characteristics such as age and level of physical activity. However, no
demographic statistics other than age were supplied.
Menstrual phase and NE. NE and other catecholamines also appear to be affected by
menstrual phase and gonadal hormones. However, much of this evidence comes from animal
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studies or research into the relationship between the catecholamines and the general
physiological states (e.g., blood pressure) that have been linked to both the sympathetic stress
response and risk of cardiovascular disease. For example, in a study of female sheep
(Komesaroff et al., 1998) experiencing either a metabolic or an audio-visual stressor, NE
response was found to be attenuated during the follicular phase relative to the luteal phase. A
small, early human study (Goldstein, Levinson, & Keiser, 1983) likewise reported that plasma
NE was significantly elevated in the luteal phase among six hospitalized, but healthy women
who were followed throughout their ovulation cycle.
Cardiovascular risk studies. In studies investigating cardiovascular disease risk, which
often assess similar physiological arousal metrics as those examined in anxiety and PTSD
studies, both Girdler, Pedersen, Stern, and Light (1993) and Tersman, Collins, and Enroth (1991)
looked at the effect of menstrual phase on blood pressure. The former (Girdler et al., 1993)
found that blood pressure did not significantly vary between the follicular and luteal phases
among the 30 subjects when exposed to either cold pressor or a speech stress. Tersman and
colleagues (1991) also reported no effect of menstrual phase on blood pressure among fifteen
females exposed to a mental arithmetic test. However, when those same women were given a
cold pressor test, a significant blood pressure increase was detected during the luteal phase.
These results contrast with Sita and Miller (1996), who looked at both menstrual phase and level
of endogenous estrogen with respect to heart rate and blood pressure. Female undergraduates
(ages 18-35) were subjected to multiple stress tasks in counterbalancing order, with blood
samples taken after each task. Cold pressor exposure during the luteal phase was associated with
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both elevated estrogen and attenuated heart rate and blood pressure. Average premenopausal
estrogen levels are generally higher during the luteal phase relative to the follicular phase
(Rasmusson & Friedman, 2002).
Three other cardiovascular risk studies randomized women to either estrogen or placebo
administration, presented a stressful stimulus, and measured any resulting catecholamine
response. Ceresini et al. (2000) subjected postmenopausal women (N = 10; mean age = 53.9
years) to mental stress using an arithmetic test and found no significant difference in plasma NE
between the estrogen and placebo conditions. They did, however, find that estrogen
administration was associated with a significant decrease in the related catecholamine
epinephrine. In the Komesaroff et al. (1999) study of perimenopausal females (N = 12), those
receiving estrogen showed a significantly reduced NE response after stress from a mental
arithmetic task compared to placebo. Sofowara, Singh, He, Wood, and Stein (2005) detected a
significantly increased NE response to mental stress among 19 postmenopausal subjects (mean
age = 54) for the estrogen condition relative to control, but no NE difference after cold pressor
stress. However, these researchers only administered estrogen for 36 hours prior to stress
exposure compared to 3 weeks for Ceresini et al. (2000) and 8 weeks for Komesaroff et al.
(1999).
There appears to be conflicting evidence regarding estrogen’s relationship to the
sympathetic response from studies linking cardiovascular reactivity and menstrual phase.
Perhaps this ambiguity might be mitigated with increasing use of newer, more discriminatory NE
measures such as microneurography (Rasmusson & Friedman, 2002). However, considering

37
these varying results together with NE’s association with PTSD, it seems reasonable that
fluctuating gonadal hormones in women may be a contributing factor to the gender difference in
PTSD.
Gender differences related to NPY. Research into any NPY gender differences are in
the very beginning stages. Zukowska-Grojec (1995) reported that when ovariectomized women
were compared to age-matched men, females exhibited a lower plasma NPY increase than males
in response to exercise stress. When the women later received estrogen replacement therapy,
their stress-induced NPY increase disappeared--suggesting that estrogen inhibits NPY. More
recently, Karl, Duffy, and Herzog (2008) studied male and female mice that were NPY-deficient.
Both sexes showed increased anxiety-like behavior in locomotion and exploration tasks, but this
effect was stronger among the male mice. This could mean that when an NPY deficiency exists,
males are more detrimentally affected than females. However, more human studies are
necessary to know whether such a distinction will hold between men and women.
There is also evidence that menstrual cycle changes in gonadal hormones may affect
NPY. While one rodent study investigating depression (Jimenez-Vasquez, Overstreet, & Mathe,
2000) failed to find any association between estrous cycle phase and NPY, a human study
looking at cardiovascular disease risk did report an NPY-menstrual cycle relationship
(Lewandowski et al., 1998). The latter researchers found that among eleven normally
menstruating women, those in the follicular stage experienced significant increases in plasma
NPY compared to basal levels when exposed to exercise stress. On the other hand,
measurements indicated no significant NPY increase from basal levels for women in the luteal
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phase. As discussed earlier, the average level of estrogen is higher during the luteal phase. This
could mean that Lewandowski and colleagues’ (1998) results are consistent with an inhibitory
function of estrogen with NPY. However, another possibility is that testosterone is also helping
regulate NPY levels. In rats, removal of the testes led to a reduction in NPY response to a cold
pressor trial (Zukowska-Grojec, 1995). This could imply that testosterone facilitates NPY
release. Indeed, Rasmusson and Friedman (2002) suggest that a facilitory role of testosterone
with NPY is an alternative explanation for the Lewandowski et al. (1998) findings since
testosterone levels peak in the late follicular phase immediately prior to ovulation.
With few human studies investigating sexual dimorphisms or menstrual effects on NPY
and stress, it is difficult to draw firm conclusions for the interplay of these factors. Preliminary
evidence indicates women have a somewhat reduced NPY response when exposed to stress and
that shifts in hormone levels due to menstruation may play a role in modulating this differential
response.
Implications for the PTSD gender difference. Thus far, there is a paucity of research
into any direct connection between these neurophysiological gender differences and the human
PTSD gender disparity. Implications must be tentatively drawn from the frequently conflicting
results of the reviewed studies. With regard to gender differences in the HPA axis and cortisol,
indications are that estrogen’s inhibition of HPA activity may foster females experiencing
periodic enhancement of stressful memories along with inhibited extinction of fear learning; both
of which would be consistent with higher rates of PTSD. The NE gender difference results were
highly ambiguous. However, if estrogen is eventually found to enhance the NE response to
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stress, women could be at higher risk of PTSD-related hyperarousal and intrusive traumatic
memories. Likewise, confirmation of estrogen’s inhibitory role and/or testosterone’s excitatory
role with NPY would point to females having increased consolidation of fear memories and
reduced attenuation of the NE-related sympathetic response.
Neurophysiological Changes Associated with Early-Life Stress
Some researchers have investigated the long-term neurophysiological consequences of
trauma suffered in formative, developmental years. Such early trauma, along with other highly
stressful circumstances like separation from parents, has sometimes been termed “early-life
stress” (ELS; Heim, Plotsky, & Nemeroff, 2004, p. 641). Indications are that ELS is associated
with longstanding, persistent changes in physiological components of the stress response.
Evidence for neurophysiological effects of ELS. Prospective animal studies with
rodents (Jimenez-Vasquez, Mathe, Thomas, Riley, & Ehlers, 2001; Liu, Caldji, Sharma, Plotsky,
& Meaney, 2000; Plotsky & Meaney, 1993) have shown evidence of HPA axis, NE, and NPY
disruptions that persist into adulthood after exposure to ELS. Research using non-human
primates (Rilling et al., 2001; Gilmer & McKinney, 2003) has similarly yielded ELS-related
changes to cortisol and NE, as well as behavioral alterations. However, these animal ELS
models typically involve stressors such as maternal separation or restraint stress that may not
correspond directly to the subset of human ELS trauma (e.g., child sexual abuse) which would
fulfill the DSM criteria for a traumatic event.
Researchers have used retrospective methods to investigate early trauma among humans.
Concentrating on hypothesized long-term effects to the HPA axis, Heim, Newport, Bonsall,
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Miller, and Nemeroff (2001) examined the relationship of childhood abuse-related ELS to
ACTH and cortisol response in 66 women (mean age = 27.8 years). The women were
categorized into four groups: 20 with no history of child abuse (comparison group), 20 with a
history of child abuse but no current diagnosis of major depressive disorder (MDD), 15 with both
a child abuse history and MDD, and 11 with MDD but no history of childhood abuse. Relative
to the comparison group, CRF stimulation resulted in an augmented ACTH response for women
with child abuse and no MDD. In contrast, the same test attenuated ACTH response in the two
groups with MDD. Another test, ACTH1-24, which allows measurement of the adrenal cortex’s
response to ACTH, yielded reduced plasma cortisol for the childhood abuse/no MDD group at
both baseline and after ACTH stimulation. These results suggest an association between child
abuse-related ELS and sensitization of the pituitary ACTH response coupled with desensitization
of the ACTH receptors in the adrenal cortex.
Similarly, Shea and colleagues (2007) found that childhood abuse was correlated with
lower basal cortisol levels among 66 pregnant women (mean age = 31.9 years). Child abuse
experience was measured using the Childhood Trauma Questionnaire (Bernstein et al., 2003).
Half of the subjects were depressed, but this relationship held even after controlling for
antidepressant use status. Likewise, a study of 20 men with personality disorders reported a
positive correlation between Childhood Trauma Questionnaire scores and CRF levels in the
cerebrospinal fluid (Lee, Geracioti, Kasckow, & Coccaro, 2005). In a sample of women (N = 39,
mean age = 31.2 years) with borderline personality disorder, Rinne et al. (2002) found that the 24
endorsing a history of childhood abuse exhibited an increased ACTH response to a combined
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dexamethasone suppression and CRF test compared to the remainder who did not endorse child
abuse. However, this study differed somewhat from the previous two in that the cortisol
response for those with child abuse was also elevated, rather than reduced.
Bremner et al. (1997b) compared the hippocampal volumes of 17 PTSD patients with a
history of childhood abuse to 17 healthy, non-abused subjects using MRI. The comparison
group subjects were matched to the PTSD subjects on several factors including age, sex,
education, etc. The PTSD/child abuse group had 12% lower volumes in the left hippocampus
than the controls. Vythilingam and colleagues (2002) also used MRI to compare hippocampal
volumes. Assessing 32 women with MDD and fourteen healthy women as controls, the authors
reported that those MDD subjects with a self-reported history of childhood physical or sexual
abuse had smaller hippocampi. Specifically, the size of the structure was reduced by 15%
compared to the controls and 18% compared to women with MDD but no history of childhood
abuse.
Of course, the retrospective design of these human studies makes it impossible to
conclude that ELS caused the neurobiological changes that have been mentioned. However,
taken together with the prospective animal studies, a reasonable case can be made that certain
types of ELS result in long-term abnormalities in the body’s stress response system.
Implications for the gender differential in PTSD. As already discussed in the section
on differential exposure to trauma, females disproportionately indicate that they have
experienced child sexual abuse when compared to males (e.g., Costello et al., 2002; Goldberg &
Freyd, 2006; Perkonigg & Wittchen, 1999; Walker, Carey, Mohr, Stein, & Seedat, 2004). Given
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increased ELS exposure in this significant area of trauma, females may be at somewhat increased
risk for ELS-related neurophysiological changes that have been associated with vulnerability to
stress disorders such as PTSD. Confirming any causal role that ELS plays in such a differential
risk will be difficult, however, without long-term, prospective studies assessing ELS, stress
response markers, and psychiatric diagnosis beginning in childhood and progressing into
adulthood.
Summary of Neurophysiology and the PTSD Gender Difference
Separate lines of research point to the complex relationship between gender, the
neurophysiology of stress, ELS, and PTSD. While the interplay of these factors may indicate an
important role for neurophysiology in the PTSD gender difference, significant questions remain.
For example, it is difficult to reconcile that most of the neurophysiological differences noted
above are relatively small in magnitude, while the majority of prevalence estimates put women at
nearly twice the risk of PTSD. Until such time that a deeper knowledge of biology might explain
such discrepancies, it seems reasonable to investigate other potential contributors to the wide
gender PTSD gap. The discussion now turns to gender differences in diagnostic criteria for the
disorder of PTSD.
Gender and PTSD Diagnostic Criteria
Differences in the Immediate Response to Trauma
The American Psychiatric Association’s (APA) DSM-IV (1994) criteria for PTSD
include a stipulation (criterion A2) that the traumatic event elicit a response of horror, fear, or

43
helplessness in the victim. It is no surprise, then, that such emotional reactions at the time of the
PTE have been positively associated with PTSD (Brewin, Andrews, & Rose, 2000a; Ozer, Best,
Lipsey, & Weiss, 2003; Vaiva et al., 2003). A related finding is that those who perceive that
their life is threatened by a trauma are also subsequently at greater risk of PTSD (Ozer et al.,
2003; Resnick, Kilpatrick, Dansky, Saunders, & Best, 1993). Some recent studies, however,
have reported that there are gender differences in such peritraumatic emotional responses and
perceptions of threat to life.
Breslau & Kessler (2001) analyzed responses on the DSM-IV PTSD trauma criterion
(criterion A) using a large sample (N = 2181; age range = 18-45 years) originally selected using
random-digit dialing. The results indicated that women were more likely than men to endorse
criterion A2 in relation to a suffered trauma (adjusted OR = 2.66, 95% CI [1.92, 3.71]). Indeed,
gender was the only factor significantly related to endorsing A2—including such seemingly
relevant factors as the type of event experienced. A smaller, longitudinal study of criterion A2
(Brewin et al., 2000a) came to similar conclusions. The authors obtained a convenience sample
consisting of victims of violent crime recruited through local police and hospitals (N = 138; 75%
male; mean age = 36.7). Those subjects reporting that they experienced intense fear,
helplessness, and/or horror at the time of the traumatic event were more likely to be identified as
having PTSD at six months. Also, both fear and horror were found to be significantly correlated
with female gender.
Vaiva and colleagues (2003) conducted a longitudinal study looking at the relationship
between peritraumatic fright and later PTSD status among a sample of consecutively hospitalized
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victims of MVA (N = 123; 68% male; mean age = 31.3). A fright reaction was determined to
have occurred when a victim voiced the perception that their life was threatened and identified
experiencing a subsequent lack of thoughts, words, or similar. MVA victims who were judged to
have experienced such a fright response in reaction to the trauma were much more likely than
those who did not identify a fright reaction to be diagnosed with PTSD (OR = 16.75). With
respect to gender differences, females were reported to have a higher likelihood of indicating a
peritraumatic fright reaction (χ2 = 7.4, d.f. = 1, p = .007). However, possibly due to the relatively
small sample size, there was no significant PTSD gender difference. Nonetheless, a couple of
relatively small studies (Bryant & Harvey, 2003; Fullerton et al., 2001) associated a
peritraumatic dissociative reaction with higher risk for subsequent PTSD, and reported that
females were more likely to identify such a reaction at the time of the trauma. Both studies also
found that women with peritraumatic dissociation were far more likely than men with the same
to later receive a PTSD diagnosis.
While these limited results are hardly conclusive, they are suggestive of a role for gender
differences related to peritraumatic reactions in influencing the observed PTSD differential
between males and females. Since such an emotional reaction is a necessary component of any
formal PTSD diagnosis, further investigation of possible gender differences in this area is
warranted.
Gender Differences in PTSD Symptom Reporting
There is some evidence that, at the statistical level, women tend to respond to symptom
queries on PTSD instruments in a pattern that is unique compared to men. Before reviewing this
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literature, however, a brief discussion of the organization of PTSD symptoms organization is
necessary. The DSM-IV (APA, 1994) recognizes three official symptom clusters consisting of
reexperiencing (also referred to as intrusion), avoidance/numbing, and hyperarousal. Multiple
studies using factor analysis have suggested that four clusters would be more appropriate with
numbing and avoidance separated into distinct symptom categories (see Asmundson, Stapleton,
& Taylor, 2004, for a review). Although the subject PTSD instrument, the PC-PTSD screen,
uses the four cluster framework, both conceptual approaches are employed in the reviewed
studies that follow. Depending on how the various researchers conceptualized the constructs,
avoidance and numbing will sometimes be discussed jointly and at other times as distinct
subclusters.
Reexperiencing/Intrusion. Norris, Perilla, Ibanez, and Murphy (2001) used a crosssectional, retrospective design to look at two groups that had been exposed to serious
neighborhood hurricane damage. The researchers used purposive sampling in order to include
approximately equal proportions of both sexes and younger, middle aged, and older subjects.
The Mexican sample (N = 200) and the U.S. sample (N = 270; 50% white, 50% AfricanAmerican) were interviewed using the Revised Civilian Mississippi Scale for PTSD (Norris &
Perilla, 1996) six months post-disaster. This 30-item instrument is not directly linked to the
seventeen individual symptoms included in the DSM-IV diagnosis of PTSD.
Results indicated that, compared to males from the same culture, US white women, US
black women, and Mexican women all exhibited elevated intrusion subscale scores, as well as
higher overall PTSD scores on the PTSD instrument. However, each of these groups of women
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also had significantly higher scores than comparable men in the avoidance/numbing cluster, and
only the African-American females from the US were not also higher on the third PTSD
symptom cluster of arousal. These particular results on intrusion, therefore, appear to be
representative of a generally increased response to all PTSD clusters rather than a gender
disparity specific to the reexperiencing/intrusion cluster.
Amir and Sol (1999) reported that in their large convenience sample (N = 983) exposed
to political violence, the intrusion subscale scores were higher for women than men. This result
was consistent across two instruments: the IES and the PTSD Scale (Horowitz, Wilner, &
Kaltreider, 1980). On the PTSD Scale, intrusion was the only subscale that was differentially
elevated for females. While the IES, like the Revised Civilian Mississippi Scale for PTSD, is not
directly linked to the DSM PTSD symptoms, the PTSD Scale’s seventeen items do so
correspond.
Avoidance and Numbing. In Breslau et al. (1999), the researchers used a three-cluster
approach to reanalyze the epidemiological data used in the Breslau et al. (1998) investigation.
When examining symptom differences among the subgroup exposed to assaultive violence,
women were more likely than men to meet the cluster criteria for reexperiencing,
avoidance/numbing, and hyperarousal. However, avoidance and numbing exhibited the largest
disparity, with females nearly three times as likely as males (ratio of women to men = 2.8:1) to
meet criteria for that cluster. Comparison of all three symptom cluster gender ratios revealed
that the difference between the avoidance/numbing ratio and the reexperiencing ratio (1.5:1) was
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significant (p = .031), while the difference between the avoidance/numbing and hyperarousal
(1.8:1) ratios approached significance (p = .062).
Other evidence is also suggestive of differences between men and women in the area of
avoidance and numbing. One study (Fullerton et al., 2001) found that females were significantly
more likely than men to endorse that cluster of symptoms (OR = 4.71). Another (Norris et al.,
2001) reported that white women, Mexican women, but not African-American women, scored
significantly higher on the avoidance/numbing subscale. Within that cluster and without respect
to culture, women were more likely than men to endorse two items that assessed avoiding
reminders of the traumatic event and two items that addressed emotional numbing. Finally,
Amir and Sol (1999) indicated females had significantly higher scores than males on the
avoidance subscale of the IES, but not on the PTSD Scale.
Some recent work viewing avoidance and numbing as separate constructs has pointed to
the pivotal nature of one or the other symptom in the diagnosis of PTSD. For example, in a
validation study examining both the PC-PTSD screen and a diagnostic checklist for PTSD
among combat veterans returning from deployment (Bliese et al., 2008), an item response theory
analysis revealed that the highest information was provided by two avoidance items. In fact, on
the PTSD screen a single question about avoidant behavior performed about as well as the full
four item screen for identifying a probable positive PTSD diagnosis. However, this study’s
sample had an extremely small proportion of females (2% to 4%, depending on the particular
analysis) and no information was reported on gender differences.
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A couple of recent studies have illuminated Breslau and colleagues’ (1999) findings with
evidence that emotional numbing plays a crucial role in more severe PTSD cases. Chung and
Breslau (2008) used the four-cluster model of PTSD to look at the relationship between gender
and PTSD symptoms within the context of three severity classes of the disorder (pervasive
disturbance, intermediate disturbance, and no disturbance). In this large (N = 1360), but nonrandom, sample of young adults (mean age = 21 years) from a mid-Atlantic city, no gender
differences were detected within the three disturbance classes in the rate of reporting symptom
clusters. Instead, results indicated a connection between being violently assaulted and higher
rates of emotional numbing. Interestingly, though, women who had been violently assaulted
were more likely than male violent assault victims to be judged as having pervasive disturbance.
Similarly, Breslau, Reboussin, Anthony, and Storr (2005) found that assaultive victimization
resulted in a more elevated risk of pervasive disturbance for women than for men, with the
pervasive disturbance class exhibiting a strong association with DSM-IV PTSD. Breslau and
colleagues (2005) analyzed both the sample from Breslau et al. (1998) and the sample later used
by Chung and Breslau (2008). An important additional finding was that for both males and
females the emotional numbing category of symptoms was rarely identified outside of pervasive
disturbance, prompting these authors to speculate that emotional numbing may be a “marker”
(Breslau et al., 2005; p. 1350) for a PTSD diagnosis.
Taken together, these three studies (Breslau et al., 1999; Breslau et al., 2005; Chung &
Breslau, 2008) raise the question of whether there is a connection between gender, assaultive
violence, and emotional numbing. Given that females are disproportionately exposed to sexually
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assaultive violence and that sexual assault is among the traumata most likely to result in PTSD
(Gnanadesikan, Novins, & Beals, 2005; Resnick et al., 1993), further investigation is warranted
regarding gender differences in emotional numbing and particular types of violent assault.
Arousal. A couple of the studies already cited for the reexperiencing/intrusion and
avoidance/numbing symptoms of PTSD also provide evidence of a gender differential in arousal
symptom reporting. Norris and colleagues (2001) reported that in regression analyses of cluster
subscale scores conducted across all studied cultures, gender was predictive only of arousal (not
reexperiencing/intrusion or avoidance/numbing). Females were significantly more likely to
score positive on the arousal cluster. Fullerton et al. (2001) likewise indicated a higher
likelihood of women than men endorsing the arousal cluster (statistically significant OR = 3.8).
Conclusion of symptom differences. Of the reviewed studies, a number found
evidence that women were more likely than men to endorse multiple, or even all PTSD symptom
clusters. This could imply that the PTSD gender difference is at least partly the result of
females’ more frequently responding “yes” when queried about PTSD symptoms. Only one
study showed uniquely increased intrusion reporting for females, and that on only one of two
instruments (Amir & Sol, 1999). However, multiple studies provide limited evidence that the
gender difference in symptom reporting may be more pronounced for the avoidance/numbing
cluster (Breslau et al., 1999; Fullerton et al., 2001), and perhaps with the arousal cluster, as well
(Fullerton et al., 2001; Norris et al., 2001). Finally, studies separately linking both female
gender and assaultive violence to emotional numbing (Breslau et al., 1999) and to a pervasive
disturbance class associated with DSM-IV PTSD (Breslau et al., 2005; Chung & Breslau, 2008)
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give indications that gender may be interacting in complex ways with particular types of trauma
to produce unique symptom reporting.
Summary and Connections to Current Study
Summary of PTSD Gender Differences
Prevalence and trauma exposure. Despite a history predominantly focused on males,
the diagnosis of PTSD has generally been shown to occur disproportionately among females in
both epidemiological and non-epidemiological prevalence studies. This gender disparity appears
to hold across international borders and among children as well as adults. Even though women
are at greater risk of PTSD, trauma prevalence studies are in relative agreement that women
report fewer traumatic events than men. This indicates that the simple average number of
traumas experienced for males and females is not an adequate explanation for the PTSD gender
difference. Rather, a closer look at the PTE research reveals that men and women are at
uniquely elevated risk for particular types of trauma. Men tend to face more accidents, combat,
and physical assaults, whereas women more often deal with sexually assaultive traumas—
although evidence points to growing combat exposure for women. Of the most common types of
traumatic event, sexual trauma (Kessler et al., 1995; Norris, 1992) and combat (Kessler et al.,
1995; Kulka et al., 1990) have been associated with higher risk for PTSD subsequent to
exposure. Thus, differential exposure to particular types of trauma may account for some of the
differential risk of PTSD among genders.
Neurophysiology. Neurophysiological differences between men and women constitute
another potential contributing factor. Studies looking at the effects of estrogen level variation on
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stress-related neurochemicals such as cortisol and NPY have shown some promise for informing
the gender PTSD difference. However, at the current time there is no research directly linking
differential PTSD risk with biological gender differences. Additionally, the measured changes in
these neurochemicals is generally very small—making it difficult to conceive of how such
modest changes could lead to the relatively substantial observed PTSD prevalence differences
between men and women. Nonetheless, limited extant evidence suggests that more than one
neurobiological system has the potential for influencing gender differences in the area of
stressful memory acquisition and fear conditioning.
Research into ELS provides a possible connection between the neurobiology of PTSD
and differential trauma exposure. With ELS associated with neurophysiological changes that are
elsewhere linked to PTSD, it appears plausible that women’s disproportionate exposure to child
sexual abuse could result in a gender difference in ELS-related biological vulnerability to PTSD.
Peritraumatic reactions. Relatively few studies have examined gender differences and
PTSD as they relate to the response to trauma and subsequent social support. Among immediate
reactions to trauma, the strongest evidence indicates that the peritraumatic emotion of fear,
which is associated with greater PTSD risk, is also more often reported by women than men.
Likewise, peritraumatic dissociation has been linked to higher rates of later PTSD; with the
limited research in this area showing that such dissociation leads to significantly higher PTSD
risk for women than for men.
PTSD symptom reporting. Dissociation, as defined in the DSM-IV criteria for ASD
(APA, 1994), contains an element of emotional numbing. This conceptual relationship between
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dissociation and emotional numbing suggests an interesting potential connection between gender
differences in both peritraumatic dissociation and symptom reporting. Perhaps a dissociative
reaction at the time of the trauma is somehow connected to persistent emotional numbing as a
coping mechanism. If this progression were to occur more frequently among women than men,
whether across all traumas or a specific subset of traumas such as violent assault, this could
provide yet another potential mechanism leading to differential PTSD risk. While not conclusive
at this point, some evidence points to more frequent reporting of numbing and/or avoidance
PTSD symptoms for women as compared to men. One large study (Breslau et al., 2005) found
that for both genders emotional numbing was strongly associated with pervasive a disturbance
level linked to PTSD. Moreover, among those subjects that have been violently assaulted,
emotional numbing appears to be an especially pronounced feature with females.
The symptom cluster of arousal has also been shown to have a gender difference in a
couple of studies (Fullerton et al., 2001; Norris et al., 2001). Again, women reported
significantly more arousal symptoms than men. Evidence for a gender differential for intrusion
symptoms can be found in two studies, as well (Amir & Sol, 1999; Norris et al., 2001), and may
have some support in the above mentioned neurophysiological sex differences that suggest
possible enhanced stressful memory consolidation for women under certain circumstances.
However, the particular results showing elevated intrusion symptoms for females in Norris et al.
(2001) appeared to be part of a larger pattern of increased female endorsement of all PTSD
symptom clusters.
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Areas for Possible Research
While knowledge of the neurobiological bases of PTSD and stress continues to grow, it is
clear that large gaps remain. The bulk of the research, so far, has been performed using animal
subjects. More work is needed to foster our biological understanding of PTSD and the human
stress response. For example, research indicates that NPY may inhibit fear-related memory
consolidation. One hope is that further delineation of how such memories are processed from a
biological perspective would be helpful for learning the best avenues of PTSD intervention—
whether psychotherapeutic or pharmacological or some combination—for a particular patient
with given NPY levels.
Also, little is known about underlying neurophysiological processes involved in either
peritraumatic responses or subsequent PTSD symptom reporting. For instance, what are the
contributing biological factors in what appear to be unique gender responses contemporary to a
traumatic event? Similarly, a dearth of physiologically-oriented research has investigated what
leads men and women to endorse differing patterns of symptoms in PTSD. Perhaps future
efforts will provide connections between estrogen- or menstruation-linked gender differences in
the neurochemicals mentioned above and particular symptoms that are more likely to be
endorsed by either females or males.
One possible direction for future work in this area is with NE. Elevated levels of this
neurotransmitter have been linked to increased arousal and intrusive memories. Thus, settling
the question of whether estrogen enhances or diminishes the NE stress response could open
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further avenues to investigate whether differences in such gonadal hormones are related to the
observed gender differences in PTSD symptoms such as hyperarousal and intrusion.
With the limited, but important evidence connecting peritraumatic emotional and
dissociative reactions to elevated PTSD risk for women, further investigation would be helpful.
Specifically, what are needed are prospective, longitudinal studies initially assessing immediate
reactions to trauma and subsequently measuring for PTSD diagnosis. It will be crucial for such
studies to have sufficiently large male and female sample sizes to provide the statistical power to
detect any overall gender PTSD difference. Unfortunately, it can be challenging to achieve large
samples with a prospective design due to the need to quickly identify and assess those who have
experienced a trauma. Perhaps telephone interviews conducted with a large population—a
design which was used in many of the reviewed epidemiological prevalence studies—would be
helpful in this regard.
Whatever the specific etiology of the PTSD gender gap, clearly the result is that when the
diagnostic criteria for PTSD are applied to women, they are more likely than men to meet
sufficient criteria for a positive diagnosis. With various measurement instruments being the
predominant method for determining the presence or absence of PTSD in most prevalence
studies, it is important to ensure that the tests themselves are not biased toward diagnosing
women. This issue is potentially related to the gender symptom differences in that many of these
PTSD instruments are directly linked to the DSM criteria for the disorder—including the
symptoms (Cusack et al., 2002). Therefore, an important possible factor for consideration when
examining the PTSD gender disparity is that the instruments themselves may be biased toward
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diagnosing females with PTSD. A preliminary search revealed no differential functioning or
measurement equivalence studies of PTSD instruments using males and females as the
comparison groups.
As suggested by Kimerling and colleagues (2007), studies testing measurement
equivalence of common PTSD instruments across genders would be helpful for ruling out
differential functioning, or test bias of PTSD tests for women versus men. If measurement
equivalence by gender holds for the instruments that are evaluated in this fashion, one important
result would be increased confidence that the reviewed gender differences are not merely
artifacts of biased PTSD measurement. Such an evaluation is the primary focus of the current
study. The target instrument is the PC-PTSD screen used extensively by the US military.
Primary Care-PTSD Screen
The PC-PTSD consists of four dichotomously scored (Yes/No) items meant to assess the
four main symptom clusters of PTSD: reexperiencing, avoidance, arousal, and numbing. See
Figure 1 on the next page for the PC-PTSD screen as it is configured within the PDHRA. All
subsequent tables and figures will likewise be located on the page immediately following the
page where the table or figure was mentioned in the text. Initial validity and reliability was
examined using a sample of primary medicine patients (N = 188; 66% female) from one
Veteran’s Administration (VA) facility with the Clinician-Administered PTSD Scale (CAPS;
Blake et al., 1995) serving as the gold standard (Prins et al., 2003).
Sensitivity and specificity were highest with cutoff scores of two and three positive
responses. A cutoff of two was better for sensitivity at .91, with specificity at .72.
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12. Have you ever had any experience that was so frightening, horrible, or upsetting that, IN THE PAST
MONTH, you….
a. Have had nightmares about it or thought about it when you did not want to?

Yes/No

b. Tried hard not to think about it or went out of your way to avoid situations that remind you of it? Yes/No
c. Were constantly on guard, watchful, or easily startled?

Yes/No

d. Felt numb or detached from others, activities, or your surroundings?

Yes/No

Figure 1. The Primary Care Posttraumatic Stress Disorder (PC-PTSD) screen as it is configured
within the Post-Deployment Health Reassessment (PDHRA).
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Three affirmative responses were determined to be optimal, though, diminishing sensitivity to
.78 while improving specificity to .87. When applying the cutoff of three to each gender the
authors received somewhat different results. For males sensitivity was .94 and specificity was
.92, yielding a diagnostic efficiency of .92. The figures for females were lower with sensitivity
at .70, specificity at .84, and efficiency at .81. The researchers speculated that the lower
performance at this cutoff level with women may have resulted from females’ measured PTSD
symptoms being differentially affected by factors such as comorbidities with PTSD and PTSD
course length.
Bliese and colleagues (2008) recently validated the PC-PTSD against a modified PTSD
module of the Mini International Neuropsychiatric Interview (MINI; Sheehan et al., 1998) with a
sample of active duty soldiers (N = 352; 96% male) returning from combat. Their analysis
yielded similar results, with shifting from a two “yes” cutoff to a three “yes” cutoff diminishing
sensitivity from .85 to .76 while improving specificity from .71 to .88. The researchers also
found that using the avoidance question alone as a single-item screen yielded a diagnostic
efficiency approximately between that provided by the two- and three positive response cutoffs.
However, with only 13 females (4%) the validation sample was overwhelmingly male, leaving
this study’s generalizability to women open to question.
Army researchers in Europe (Bliese et al., 2004) conducted a validation study of a screen
for multiple psychological issues that included the PC-PTSD as one element. The sample (N =
528) consisted of soldiers returning from a deployment to Iraq. Clinical interviews were
conducted using the modified MINI (Sheehan et al., 1998) to provide the standard against which
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the screen was validated. These authors found that a cutoff of two resulted in sensitivity of .73
and specificity of .88. A three cutoff, on the other hand, yielded sensitivity of only .46 but a
specificity of .97. Three was chosen as the optimal cutoff since specificity was favored due to
the need, identified prior to the study, to minimize false positives. However, the sensitivity at
this cutoff was very low (.46). Also, this study provides no indication of what proportion of the
sample was female.
As these three validation studies establish, current recommendations for the PC-PTSD are
that a score of three (out of four) is indicative of a probable PTSD diagnosis (Bliese et al., 2008;
Prins et al., 2003). However, within the USAF a positive response on any one of the four PCPTSD items results in supplemental testing and a referral for face-to-face follow-up (Office of
the USAF Surgeon General, 2008). This approach equates to using a cutoff of at least one
positive PC-PTSD item. The PC-PTSD has thus far not been evaluated with a sample of
returning military deployers that includes a significant proportion of females. Also, none of the
published PC-PTSD validation research addresses measurement equivalency across groups,
including gender.
Research Questions
The PC-PTSD is yet to be evaluated with a sample of returning military deployers that
includes a significant sample size of females. Also, none of the published PC-PTSD validation
research addressed measurement equivalency across gender. The questions pursued in this study
arise from these issues as well as the areas for further research previously identified in this
chapter. These research questions are as follows:
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Research Question 1: Are the parameters of the PC-PTSD items consistent across groups
of returning male and female USAF Iraq and Afghanistan deployers (the target population)?
Research Question 2: Does the PC-PTSD, in various scoring configurations including
the recommended cutoff of three, differentially predict a clinical diagnosis of PTSD for men and
women in the target population?
Research Question 3: Does the proposed single-item screen version of the PC-PTSD,
using only the avoidance item, differentially predict a clinical diagnosis of PTSD for males and
females in the target population?
Research Question 4: Is the diagnostic utility of the PC-PTSD consistent when used with
men versus women in the target population?
Research Question 5: Does the PC-PTSD demonstrate good convergent and discriminant
validity when used with a sizable sample of the target population?
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CHAPTER III: METHOD
Sources of Data
There were two USAF datasets used as the sources for the data in this study: the PDHRA
database and the military electronic medical record system. There are actually two PDHRA
databases containing responses on all screening items. An older database includes responses
from 2005 to 2007 on a previous version of the PDHRA. The database used for the present
study is linked to the PDHRA as revised in 2008 and includes response data for 2008 and 2009.
The PC-PTSD is identical in both PDHRA versions. The military electronic medical record
system records data on all military medical visits for all members of the USAF.
Institutional Review Board (IRB) permission was sought from the Human Subjects
Committee of the College of Social Work at the University of Tennessee using Form A
(Certification for Exemption from IRB Review for Research Involving Human Subjects). The
exemption was granted based on Category 4, which applies to research utilizing existing data
under the condition that the investigator records the information in a manner that precludes
personal identification of the subjects. Approval for the study was also requested from the Air
Force Research Laboratory (AFRL) IRB at Wright-Patterson Air Force Base, Ohio. This body
ruled that, under federal regulations, the current study did not constitute human subjects research
due to the use of pre-existing data that had been de-identified and, consequently, no AFRL IRB
approval was required.
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PDHRA Database
Two post-deployment screenings containing the PC-PTSD are given to returning
deployers in the USAF (and in the DoD, in general). The first occurs concurrently with an
airman’s return from deployment. This screening program was the first to be implemented and
was termed the Post-deployment Health Assessment (PDHA). Subsequently, though, research
with a matched sample of US Army soldiers returning from a year-long deployment to Iraq
(Bliese et al., 2007) showed convincing evidence that prevalence of PTSD and other mental
health-related problems increased during the six months postcombat.
Bliese and colleagues (2007) is the only study to date examining changes over time in
mental health prevalence after exposure to combat. The researchers conducted assessments for
PTSD, depression, and other problems during a seven day “reintegration program” (Bliese et al.,
2007, p. 143) with over 1500 soldiers immediately upon their return from deployment. Four
months (about 120 days) later, 509 randomly sampled soldiers were selected from those who
took the original assessment to receive the identical assessment instruments. Results indicated
PTSD prevalence significantly increased from either 1.39% to 4.81% or 2.98% to 8.42%,
depending on whether a standard or liberalized cutoff of the Posttraumatic Stress Disorder
Checklist (PCL; Weathers, Litz, Huska, Herman, & Keane, 1993) was used. With the one
exception of relationship problems, the prevalence of all other measured mental health problems
also increased significantly during this time period. In fact, the pre-publication knowledge of
these results was one reason that the DoD instituted the PDHRA in 2005 to supplement the initial
PDHA (Bliese et al., 2007).
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Given these results, it was decided that the present study would use the later PDHRA
rather than the PDHA database to assess the PC-PTSD screen. A screen assessing for PTSD
would likely encounter more positive responses during the period 90 to 180 days postdeployment (which encompassed the 120 day postcombat timing used in Bliese et al., 2007) than
immediately after a deployment ends.
The PDHRA process itself is largely automated, although there are personnel designated
at each military medical facility who are responsible for administration of the system. At the
appropriate time, a USAF computer system prompts an email to be sent to each recent deployer
requesting that they complete the online survey. If the PDHRA screening is positive for any of a
number of pre-identified subscales, the member will be referred for further assessment with an
appropriate medical and/or behavioral health provider (Office of the USAF Surgeon General,
2008).
Medical Record Database
The USAF employs an electronic medical record system containing data for all medical
and mental health diagnoses received by all USAF members when under the care of DoD
providers. Specifically, each medical encounter for an individual contains codes for any
diagnoses (including a code for “no diagnosis”) received during the visit and any associated
procedures performed by the practitioner.
In this study, medical diagnostic information was linked to subjects’ PDHRA data in the
following fashion: For every PDHRA respondent during 2008 and 2009, the researcher merged
the PDHRA data by common study case number with the medical record database containing all
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medical visits for each subject. Then, information was extracted regarding the dichotomous
presence or absence of both a PTSD diagnosis and a major depressive disorder diagnosis during
any medical encounter in the 90 day period after the date the subject completed the PDHRA. All
other diagnoses were ignored and deleted from the study datasets.
Design
This was a non-experimental validity study of a PTSD screen using secondary data from
a large population of male and female USAF veterans of Iraq and Afghanistan. The first part of
the investigation evaluated whether the PC-PTSD (Prins et al., 2003) screen was measuring
PTSD risk with equal validity for both men and women. IRT DIF methods were employed to
detect measurement inequivalence at the item level. This measurement equivalence phase
sought internal evidence of differential validity since the analysis did not make use of any
criterion external to the screen itself (Camilli, 2006). Instead, only the item response data were
analyzed.
The second phase focused on investigating external evidence of validity in the
instrument. This part of the study looked for “differential prediction” (Camilli, 2006, p. 231) by
gender through a comparison of responses on the PC-PTSD to a subsequent PTSD diagnosis.
For the concurrent validity analyses, the predicted criterion was the presence or absence of a
clinical diagnosis of PTSD as recorded in the military medical record database within 90 days of
taking the PDHRA. Divergent validity was evaluated by performing similar comparisons
between the PC-PTSD responses and the dichotomous presence/absence of a diagnosis of major
depression (also within the 90 day time frame and from the same medical record database).
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Predictive validity was assessed using both logistic regression methods and standard
diagnostic utility statistics. Both methods were used because, although regression readily
provides statistics for evaluating model fit and hypothesis testing, diagnostic utility yields
statistics that are at once relatively simple to understand and practically useful for aiding a
clinician in diagnostic or treatment decisions related to the scale.
Finally, since the DoD is using the PC-PTSD to screen for PTSD with all returning
military deployers, this study presented a unique opportunity to assess the overall validity of the
PC-PTSD with a very large sample of males and females from that target population. To that
end, convergent and discriminant validity were additionally assessed using confirmatory factor
analysis (CFA) methods.
Variables of Interest
Dependent Variables
PTSD status. For the predictive validity study, the dichotomous outcome variable is
PTSD diagnosis status. Positive PTSD status is defined as the presence of a clinical PTSD
diagnosis during any military medical encounter within 90 days of completion of the PDHRA, as
recorded in the electronic medical record database. Conversely, negative PTSD status is
determined when no medical encounters during the 90 days after PDHRA completion indicated a
clinical PTSD diagnosis.
Major depressive disorder (MDD) status. The dependent variable (DV) for the
divergent validity analysis is MDD diagnosis status. For the purpose of this study, MDD
encompasses two separate diagnoses: MDD, single episode and MDD, recurrent. The reason for
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including both is that they each require meeting the criteria for a major depressive episode.
Since this variable is being used only to establish discriminant validity for the PC-PTSD screen,
whether or not a subject has experienced one or multiple major depressive episodes is of little
concern in this study. Like positive PTSD status, positive MDD status is defined as the presence
of a clinical MDD, single episode or MDD, recurrent diagnosis during any military medical
encounter within the 90 days after responding to the PDHRA. Negative MDD status
corresponds to the case when no medical encounters during the 90 day post-screening period
resulted in either a MDD, single episode or a MDD, recurrent diagnosis.
The MDD diagnosis was chosen to test for discriminant validity because, as mentioned in
the introduction, depression is highly comorbid with PTSD. In fact, in the National Comorbidity
Survey (Kessler et al., 1995) major depression exhibited the highest comorbidity with PTSD for
women and was a close second to substance abuse among men. The rationale was that if the PCPTSD could discriminate between PTSD and a disorder that commonly co-occurs with PTSD,
this would imply strong divergent validity for the scale.
Independent Variables
Risk of PTSD. For all analyses assessing for external evidence of validity, PTSD risk as
measured by the PC-PTSD screen was the primary independent variable (IV). Various cut
scores and PC-PTSD responses were used as the determinant for risk, as suggested by previous
research or standard USAF practice. A cut score was defined as being met whenever a subject
responded positively to a predetermined number of PC-PTSD items equal to or greater than the
chosen cut score. For example, a subject meeting the cut score of 3 on the PC-PTSD responded
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positively to any three items or to all four items. Subjects not meeting a cut score of 3 responded
positively to zero, one, or two PC-PTSD items. The actual PC-PTSD response values that were
chosen to represent PTSD risk in each analysis will be delineated in the sections below detailing
the regression and diagnostic utility analyses.
Gender. A subject’s gender was determined by the “Sex” field in the demographics of
the PDHRA database. For the purposes of this study, the terms “sex” and “gender” are used
interchangeably. Gender (male or female) was used to determine reference and focal group
membership in the IRT DIF analysis, as a moderator variable in the regression analyses, and as a
grouping variable in the diagnostic utility analyses.
Subjects
Subjects were male and female members of the USAF who had participated in the
PDHRA screening during 2008 and 2009 within 90 to 180 days of returning from deployment to
Iraq and Afghanistan. The DoD requires that every returning deployer is provided the
opportunity to participate in this screening within 90 to 180 days of returning from their
deployment. However, the screening program is essentially voluntary and, therefore, not every
USAF member returning from deployment completes the PDHRA (Office of the USAF Surgeon
General, 2008). No information was available on those who opted not to complete the PDHRA.
Missing Data
Listwise deletion was employed for all missing data. The potential risk with listwise
deletion is twofold: attenuated statistical power and a less representative remaining sample
(Saunders et al., 2006). However, all analysis sample sizes were relatively large and contained
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less than 2% of cases with missing data. Under these circumstances, the risks associated with
listwise deletion are minimized (Saunders et al., 2006).
The only variable of interest that contained missing data in the source datasets was PTSD
risk, measured by the PC-PTSD. More information on the specific proportion of cases with
missing data that were deleted is included in later sections describing the specific analysis
samples.
Exclusion Criteria
It is possible that some individuals would have deployed to Iraq and/or Afghanistan more
than once and, therefore, been given multiple opportunities to respond to the PDHRA during
2008 and 2009. If so, such individuals could have also taken the PC-PTSD multiple times.
Including more than one screening for a particular subject would result in the sample containing
paired data. Therefore, whenever a subject was found to have completed the PC-PTSD more
than once, only the most recent screening results were included in this study. Keeping the most
recent screening allowed the final sample to retain as much information as possible on the total
number of deployments for each subject. If any previous screening had been selected, that
screening’s variable for the total number of deployments would not have reflected any
subsequent deployments for which the individual had also been screened. In this study, the total
deployments variable is a demographic variable that is used to help determine the extent to
which the male and female subgroups are similar.
No identifying information (e.g., name, date of birth, social security number) on subjects
was included in the study data. Instead, each subject was given a unique case identification
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number that was unrelated to any identifying information. However, subject data did include
limited demographic information, such as gender, age, rank, military status prior to deployment
(i.e., active duty, guard, or reserve), number of deployments, and marital status. The study
sample excluded any USAF officers holding the rank of Brigadier General (O-7) or higher. This
decision was made in order to prevent inadvertent identification of particular subjects. There are
a very limited number of USAF general officers deployed to Iraq and Afghanistan at any one
time, and their roles tend to be relatively high profile. These conditions heighten the risk that the
screening results for an individual subject could be linked to their identity. Therefore, out of
privacy concerns, all general officers were excluded. All other ranks were substantially more
common in the deployed setting and were therefore included in the study data.
Samples
While all samples were derived from the same larger datasets, the different types of
analysis and variables dictated that unique samples be employed for some analyses. Following is
a discussion of the specific characteristics of each sample used in this study.
IRT DIF sample. The 9806 subjects (8381 males, 1425 females) used in the IRT DIF
study constituted the entire population of USAF Iraq and Afghanistan deployers completing the
PDHRA (including all items on the PC-PTSD) from 2008 through 2009 who responded during
the 90-180 day post-deployment window. In order to attain this final sample, 134 cases (111
males, 23 females) that contained at least one missing response on the PC-PTSD portion of the
PDHRA were removed from the total population that included missing values (N = 9940, with
8492 men and 1448 women). The overall percentage of cases with missing data that were
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removed constituted 1.35% of the larger population. While a slightly larger percentage of
women than men had cases deleted due to missing PC-PTSD responses (1.59% of women vs.
1.31% of men), an analysis of this difference using the Pearson chi-square in PASW indicated
that it was not statistically significant (χ2(1, N = 9940) = .736, p = .391).
Regression and diagnostic utility sample. The same sample was used for both the
regression and diagnostic utility analyses. It constituted a smaller, but still substantial subset (N
= 6999) of the total population used in the IRT DIF study. Of these, 5785 were men and 1214
were women. The smaller magnitude of the regression sample when compared to the IRT DIF
sample was the result of merging the PDHRA data with the electronic medical record data.
Cases were only included in the predictive validity sample if they had at least one medical
diagnostic visit within the 90 days after completing the PDHRA. This resulted in the exclusion
of 2835 subjects (2621 men and 214 women) that had been included in the IRT DIF sample.
There were a couple of purposes for applying this data criterion. The first was to ensure
that only those subjects with an opportunity for a clinical PTSD or MDD diagnosis were
included in the study sample. The second purpose was to accommodate an important
assumption: that the symptoms being measured at the time of screening were the same (or
reasonably similar to) the symptoms being considered by the clinician at the time of the medical
visit. The greater the length of time between the screening date and the subsequent diagnostic
medical encounter, the more tenuous this assumption becomes.
The resulting sample (N = 7105, males = 5871, females = 1234), however, still contained
missing responses on the PC-PTSD items. As with the IRT DIF sample, all cases with missing
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data on these items were removed to reach the final study sample of 6999. Overall, 106 (1.49%)
cases with missing responses were removed. The gender breakdown of the removed cases was
86 (1.46%) men and 20 (1.62%) women. Again, the difference in the proportion of deleted cases
was not statistically significant (χ2(1, N = 7105) = .169, p = .681).
CFA sample. The sample used for the CFA validity analysis was based on the sample
used for the logistic regression and diagnostic utility analyses. As detailed above, the regression
sample had already been purged of cases with missing data on the PC-PTSD. However, since
the CFA analysis also used data from a depression screen on the PDHRA, any cases with
missing data on the two depression screen items were deleted. This procedure resulted in 36 (29
men and 7 women) cases being deleted, reducing the sample size to 6963 (5756 males, 1207
females). Only .50% of male cases and .58% of female cases were removed and the gender
difference was not statistically significant (χ2(1, N = 6999) = .111, p = .739).
Data Analyses
Measurement Equivalence by Gender
Equivalence or invariance of measurement is said to exist when members of two
subgroups that possess equal trait or ability levels on a latent construct are observed to also
receive the same score on a given instrument measuring that construct (Drasgow & Kanfer,
1985). Of interest in the present study was whether measurement invariance holds for the PCPTSD across male and female veterans of Iraq and Afghanistan.
Differential item functioning (DIF) utilizing IRT is a common method for determining
measurement equivalence (Raju, Laffitte, & Byrne, 2002; Reise, Widaman, & Pugh, 1993). IRT
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relates an underlying construct to observed measurements and provides item response functions
that aid in the graphical analysis of the items. IRT also uses measurement invariance definitions
that do not require the latent trait score distributions among comparison groups to be identical
(Raju et al., 2002). The latter characteristic is especially helpful for detecting any measurement
inequivalence across groups. IRT DIF procedures were used in the current study for assessing
the measurement equivalence of the PC-PTSD screen across gender groups.
IRT and DIF. DIF research is an outgrowth of item bias research which began in the
1960s with studies investigating whether intelligence and selection tests were biased against
minority subjects and in favor of majority subjects (Angoff, 1993). Item bias, now commonly
referred to as DIF, can be defined as the case when an item behaves differently when used with
two population subgroups that have the same trait or proficiency level (Angoff, 1993).
IRT has been used extensively in educational and psychological measurement for years.
This theory is the foundation for many well-known tests such as the Graduate Record
Examination (GRE) and the Armed Services Vocational Aptitude Battery (ASVAB) (Embretson
& Reise, 2000). Researchers have begun to extend the application of IRT DIF methods beyond
its traditional basis in educational assessment to personality and clinical scales (see recent
examples in Baker, Caison, & Meade, 2007; Edelen, Thissen, Teresi, Kleinman, & OcepekWelikson, 2006; Hays, Liu, Spritzer, & Cella, 2007).
Assumptions of IRT. There are several IRT models, but each model provides a basic
statistical characterization of the relationship between a respondent’s unique attributes and that
individual’s response to a given item. Importantly, each item also possesses its own specific
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characteristics, or item parameters. IRT models have been devised to handle test items that yield
both dichotomous (e.g., correct or incorrect) and polytomous (e.g. partial-credit scoring and
Likert rating scales) data (Yen & Fitzpatrick, 2006).
The two foundational ideas of IRT are that (1) certain latent traits are predictive of an
examinee’s performance on a given item and (2) an item characteristic curve (ICC) describes the
relationship between the examinee’s latent traits and their performance on the item. (Hambleton,
Swaminathan, & Rogers, 1991). An examinee’s trait or ability can be referred to as a “person
parameter” (Yen & Fitzpatrick, 2006, p. 112). It is assumed that the ICC, also termed the item
response function or trace line, is an accurate representation of the relationship between the
person parameters and the responses on an item with particular characteristics. When viewed
through the lens of IRT, the definition of DIF can be modified: DIF is inferred when, after an
item is presented to two or more groups, the resulting item response functions are different
between those groups (Lord, 1980; Steinberg & Thissen, 2006).
Three additional assumptions are considered fundamental to most commonly used
models within the IRT framework: dimensionality, local independence, and parameter
invariance (Hambleton et al., 1991). Dimensionality involves the idea that a certain examinee
trait or traits constitute the “’dominant’ component or factor that influences test performance”
(Hambleton & Swaminathan, 1985, p. 17). If a model assumes that only one trait or ability
serves this purpose, the model is termed unidimensional. The local independence assumption
holds that, after controlling for relevant abilities, there is no statistical relationship between
examinees’ responses to various items within a test. This assumption states that responses on
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one test item do not influence the responses on a different test item. Rather, it is the latent
trait(s) that are the determining factors in both item responses (Hambleton & Swaminathan,
1985; Hambleton et al., 1991). Parameter invariance is the IRT assumption that item parameters
are independent of the distribution of ability in the tested population, and that person parameters
are likewise independent of the particular group of items used in a test (Hambleton et al., 1991).
Common general IRT models. An important distinguishing factor between many IRT
models is the nature and number of item parameters that the model assumes will contribute to a
person’s response (Hambleton et al., 1991). In the simplest models, only one item parameter or
characteristic is assumed to affect examinee performance: item difficulty or location (typically
denoted b). An IRT model utilizing this assumption is commonly called a Rasch model or a oneparameter logistic (1PL) model (Embretson & Reise, 2000). In IRT, item difficulty can be
thought of as the location on the scale of ability (θ) where there exists a 50% chance of a
successful response to the item. Therefore, as item difficulty increases, an examinee’s ability or
trait level must also increase in order to maintain the same probability of passing the item
(Hambleton et al., 1991).
The two-parameter logistic (2PL) model adds an item discrimination parameter (usually
symbolized a). Discrimination affects the slope of an ICC. Items possessing higher
discrimination (i.e., steeper slopes) have greater usefulness for sorting respondents into separate
trait- or ability-level categories (Hambleton et al., 1991).
A third item characteristic that can be added to an IRT model is a pseudo-chance or
pseudo-guessing parameter (designated c). The three-parameter logistic (3PL) model uses c to
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represent the probability that examinees with very low ability (approaching infinity) will
successfully respond to the item. For the 3PL model ICC, c becomes the lower asymptote of the
function (Yen & Fitzpatrick, 2006).
While the 3PL model can be applied to dichotomous response data, the 2PL model is
more frequently used (Edelen et al., 2006). Additionally, it is difficult to conceptualize the
meaning of “guessing” on an item within an instrument that assesses a trait rather than an ability
or aptitude. Therefore, in the current study the PC-PTSD data were fitted to the 2PL model.
Using the 2PL, the trace line (T) modeling the probability of an affirmative response (xi = 1) to
item i is represented in the following equation:
1

1
1

exp

(Edelen et al., 2006; Thissen, Steinberg, & Wainer, 1993) where θ is the level on the latent
construct that the test is assumed to be measuring and bi and ai are the difficulty and
discrimination parameters for item i, respectively.
Importantly, when there is a good fit between an item response model and the test data to
which the model is applied and the tested sample is of sufficient size, the resulting estimates of
the item parameters are not dependent upon the population subgroup that was tested (Camilli &
Shepherd, 1994; Hambleton & Swaminathan, 1985). Thus, comparison of item characteristics
between groups is possible under IRT. These attributes make IRT a very attractive theoretical
framework for DIF research.
As touched on in the previous paragraph, sample size is an important consideration when
using IRT. There does not appear to be any research addressing this issue in specific relation to
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the 2PL model. However, Reise and Yu (1990) recommended a sample size of at least 500 for
the graded response model. Since one perspective on the 2PL model with dichotomous
responses is that it is a special case of the graded response model (Raju et al., 2002), 500 may be
a reasonable starting point absent relevant research findings. Other general recommendations
include that the analysis utilize a sample size sufficiently large to make the parameter estimate
standard errors small enough to meet the needs of the researcher’s specific research question
(Embretson & Reise, 2000). Sample sizes for both men and women in this study were
substantially larger than 500 each.
IRT Methods for DIF. Several approaches have been devised for detecting DIF using
IRT. Examples include b-difference methods (Camilli & Shepherd, 1994; Thissen et al., 1993),
Lord’s chi-square (Lord, 1980), and Raju’s area under the curve (Raju, 1988). The current study
employed the likelihood ratio test (LRT; Thissen et al., 1993) method. LRT has been widely
used in DIF research because it is flexible enough to handle several IRT models as well as both
dichotomous and polytomous scoring regimes (Camilli, 2006; Embretson & Reise, 2000). Also,
a separate equating procedure is not required since the method itself places the item parameters
for the comparison groups onto the same metric by estimating the parameters for both groups
simultaneously (Kim & Cohen, 1995).
Kim and Cohen’s (1995) comparison study indicated that LRT performed about as well
as Raju’s area measure and Lord’s chi-square on DIF detection. In a Monte Carlo study
comparing DIF detection procedures, Finch (2005) found that LRT performed particularly well
in detecting DIF in tests containing relatively few items. This is the case for the 4-item PC-
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PTSD being evaluated in this study. Finally, the computer program MULTILOG 7.0 is available
for conducting LRT DIF analyses, in addition to other IRT applications. In this study,
MULTILOG 7.0 was implemented using the newer, more user-friendly interface as reflected in
the updated user’s guide (du Toit, 2003).
DIF procedure. In the IRT portion of this study, the LRT method was used to test for
gender DIF in the items using the 2PL. Females were designated as the focal group and males
constituted the reference group. Any items whose parameters significantly differed between the
male and female groups as evidenced by the likelihood ratio test were determined to have DIF.
Based on the review of PTSD symptom differences by gender, it was hypothesized that, if DIF
were detected, it would occur on the avoidance and numbing questions of the PC-PTSD. The
expected result would be that the b parameter on these items would be significantly lower for
females than for males.
Several steps are required to implement LRT DIF. First, prior to engaging in any
application of IRT to a particular data set, it is important to assess that the proposed IRT model
fits adequately and that the appropriate IRT assumptions are met (Hambleton et al., 1991). Next,
the LRT approach requires that DIF-free “anchor” items must be identified (Thissen et al., 1993).
These anchors are then used in the actual LRT DIF detection analysis. Finally, certain plots can
be used to aid in the interpretation of any DIF.
Checking IRT assumptions. Verifying the appropriateness of IRT assumptions can
involve both statistical assessments of model-data fit and seeking direct evidence that particular
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IRT assumptions are tenable in relation to the data (Hambleton et al., 1991). In this study both
approaches were employed.
Model fit. Methods for analyzing the overall fit of an IRT model to the data typically use
a goodness-of-fit statistic which is compared to a chi-square distribution. However, several
problems have been identified with this approach. For one, it has been shown that larger sample
sizes result in excessive identification of misfit (Hambleton et al., 1991; Stone, 2000). In this
application, these goodness-of-fit statistics also often use expected frequencies derived from
estimated, unknown trait level theta (θ) parameters. This can be particularly problematic in tests
with few items, as was the case in this study. Fewer items are linked with higher variability in θ
estimates, reducing the reliability of the associated goodness-of-fit statistic (Stone, 2000).
Therefore, as recommended by Hambleton and colleagues (1991), evaluations of specific IRT
assumptions were used to provide broader evidence of satisfactory IRT model fit.
This study employed nested model comparison methods for testing overall fit of the IRT
model to the data. Despite the limitations mentioned above, M. Orlando Edelen, who has
conducted a number of studies related to IRT DIF methods (e.g., Edelen et al., 2006; Hepner,
Morales, Hayes, Edelen, & Miranda, 2008; Orlando & Marshall, 2002; Orlando & Thissen,
2000), stated in personal communication (November 2, 2009) that model comparison remains the
most widely-used approach for this purpose. First, the model was estimated twice (with data
from males and females together): once using the 1PL model (b is the only item parameter) and
then using the 2PL (two item parameters—a and b). Then, since the only difference in these
model runs was the presence of a (slope) in the 2PL, the models were compared using negative
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two times the log likelihoods. This statistic is distributed as a chi-square with one d.f. per item
included in the models (Embretson & Reise, 2000). For the four-item PC-PTSD used in this
study, for example, the d.f. difference for this model comparison would be equal to four. As
mentioned previously, it was expected that the 2PL would be the appropriate model for these
data. The purpose of this model comparison, then, was to test whether the data were more
appropriately modeled with the 2PL than the simpler 1PL model. A similar comparison was
conducted between the 2PL and the 3PL parameterizations of the data.
In addition to evaluating model fit at the level of the test, a method was also employed to
assess model fit at the item level. Using the S-χ2 statistic, the observed and expected frequencies
were compared at every level of the total positive responses on the scale (Bjorner et al., 2007).
This statistic has been shown to minimize Type I error when compared to item fit methods that
contrast predicted and observed frequencies across levels of θ, which is an estimated value based
on the tested latent construct (Orlando & Thissen, 2000). The S-χ2 item fit statistic was
implemented by calling the IRTFIT macro (Bjorner et al., 2007) while using the SAS 9.2
statistical program.
Unidimensionality. This assumption was evaluated using tetrachoric correlations to
obtain an interitem correlation matrix. Eigenvalues from this matrix were plotted in a scree plot
and examined for indications of a dominant factor (Hambleton et al., 1991; Lord & Novick,
1968; Reise & Waller, 1990; Teresi, Kleinman, & Ocepek-Welikson, 2000). If the first
eigenvalue is much larger than the second, and the second and all remaining eigenvalues are of
similar magnitude, a single dominant dimension is indicated (Hambleton et al., 1991; Lord &
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Novick, 1968). While Hattie (1985) points out that such an approach cannot be definitive due to
a lack of empirically-determined guidelines for judging unidimensionality, Embretson and Reise
(2000) indicate that it may be useful as evidence of single-factor dominance. Indeed, Lord and
Novick (1968) state that the presence of a single common factor resulting from a tetrachoric item
intercorrelation constitutes “a sufficient but not a necessary condition for the unidimensionality
of the latent space” (Lord & Novick, 1968, p. 382). Tetrachoric correlations were obtained by
conducting an exploratory factor analysis (EFA) using Mplus 4.0 (Muthen & Muthen, 2006).
This statistical program uses tetrachoric correlation when implementing EFA with
dichotomously scored responses (Muthen & Muthen, 2004.)
CFA is frequently used to test the IRT unidimensionality assumption, as well (Embretson
& Reise, 2000). However, with so few items in the PC-PTSD there were insufficient degrees of
freedom available to allow the use of this approach with this dataset. While a model with a
single latent factor could be fit to the data, a two-factor model could not. This precluded the
requisite model comparisons.
Local independence. No separate analyses verifying local independence were conducted
in this study. This is because of the relationship between unidimensionality and local
independence. The condition of local independence is said to be met whenever all latent factors
influencing test performance have been specified. Such a circumstance can occur with either
unidimensional or multidimensional data. However, since meeting the assumption of
unidimensionality implies that there is only one dominant latent factor in the data, local
independence is likewise satisfied (Hambleton et al., 1991; Lord & Novick, 1968; Reeve, 2000).
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Parameter estimate invariance. While this, too, is an important assumption for IRT, no
separate test of this assumption was conducted in this study. In fact, an IRT DIF study by
definition looks for possible violations of this property. For example, one of the methods for
testing the parameter invariance assumption is to compare the estimates of the item parameters
obtained after giving the test of interest to more than one subgroup of the test’s target population
(Hambleton et al., 1991). These subgroups could be characterized by differences in ethnicity,
past test performance, geography, or gender. If significant variation is found for any of the
parameters across groups, it is judged that this assumption has been violated. Therefore,
performing a separate parameter invariance test in a DIF study would be redundant.
A literature search yielded no sources that explicitly discussed this possible redundancy,
but did reveal that the great majority of recent published IRT DIF studies make no mention of
testing this assumption. However, M. O. Edelen (personal communication, March 4, 2010)
confirmed that, indeed, a DIF study is a specific type of test for the parameter invariance
property and that the assumption is rarely explicitly tested in modern IRT research. A major
reason for this is that there is no accepted global test at this time, and thus it is only practical to
conduct tests for specific instances where the researcher suspects the presence of a violation of
the assumption.
Identifying anchor items. In LRT, each model also contains a set of anchor items
assumed to contain no DIF and accordingly forced to have equal as and bs. Since in each model
comparison these anchor items are common to each model, they serve the purpose of placing the
models on the same metric (Thissen et al., 1993). While multiple anchor items are typical and
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lend increased DIF detection power, it has been shown that a single item can adequately
comprise the “anchor set” (Thissen, Steinberg, & Wainer, 1988). Several methods have been
suggested in order to determine which item or items to include in this internal anchor.
The Mantel-Haenzsel (MH) test can be used to identify items with DIF and subsequently
remove those items from the anchor; leaving only those items demonstrating no MH-determined
DIF in the anchor (Edelen et al., 2006; Thissen et al., 1993). Another suggested anchoring
method is to use the LRT method itself in an iterative procedure to successively identify and
remove items that show DIF. The iterative procedure would cease after the LRT method
indicates no further DIF in any of the remaining potential anchor items (Thissen et al., 1993).
However, this purification method can be very labor-intensive (Kim & Cohen, 1995) and may
merely determine the presence of no more DIF than is common to all items (Thissen et al.,
1993).
Alternatively, Flannery, Reise, and Widaman (1995) used regression modeling to identify
anchor items and possible DIF items. The item parameters in question are first independently
estimated for each group. Then for each freely estimated item parameter, the values for the focal
group are regressed on the values for the reference group. The resulting standardized residual
values are used to analyze the items. Large standardized residuals indicate possible DIF in an
item, whereas small standardized residuals demonstrate that item’s candidacy for inclusion in an
anchor.
Another method approaches this problem graphically. Angoff’s (1982) method proposed
plotting the individual estimated parameters for the focal group against the same for the
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reference group. When, for example, the difficulty on a particular item is nearly identical
between two groups, such a plot will appear approximately linear with a correlation typically
above .98. The researcher would inspect the plot and any items that appear as outliers or that
depart from the line to a greater degree than the other items would be examined for DIF.
Accordingly, those items that most closely approximate the linear relationship are candidates for
anchoring.
Two anchor-identification methods were used in this study: Flannery and colleagues’
(1995) regression method and Angoff’s (1982) graphical method. Only items that were indicated
as DIF-free by both methods were included in the anchor. The rationale was that using two
methods would increase the confidence that the chosen anchor items could be assumed to have
equal a and b parameters across gender groups. Together, these methods were used to identify at
least one anchor item. The number of anchor items minimally necessary for detecting DIF is a
critical issue for assessing DIF in the four-item PC-PTSD. A simulation study using LRT DIF
methods found that one anchor item was sufficient to be effective in this regard—although more
anchors were related to increased detection power (Wang & Yeh, 2003).
LRT DIF detection. This approach compares the goodness-of-fit of two models. In the
augmented (A) model one or more item parameters were free to vary between the male and
female groups. In the compact (C) model the item parameters that were free to vary in the A
model were forced to be equal across the groups. Both models were estimated independently
and a log-likelihood was obtained for each. Then, the value for the LRT statistic was obtained
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by calculating negative two times the difference in the log-likelihoods (LL) of the C and A
models.
. .

2

In large samples, this statistic is distributed as a chi-square (χ2). The degrees of freedom (d.f.)
value is equal to the difference in the number of parameters in the A and C models (Camilli,
2006; Embretson & Reise, 2000; Thissen, 2001).
In order to determine DIF in both the b and a parameters individually in the context of a
2PL model, three nested models are compared hierarchically (Edelen et al., 2006; Reeve, 2000;
Thissen, 2001). Model 1 (the most unconstrained model under this DIF detection protocol)
permitted free estimation of both b and a parameters across groups. Model 2 constrained only
the slope parameter a to equality across the compared groups, freely estimating the location
parameter b. Model 3 (identical to model C above) constrained both the b parameter and the a
parameter to equivalence.
The significance of any DIF in the a parameter was tested by calculating negative two
times the difference in the log-likelihoods of Model 2 and Model 1 as in the formula above.
Rejection of the null hypothesis is indicative of a-DIF. Significance of b-DIF was similarly
determined using the same procedure for Model 3 and Model 2. The order of the model
comparisons proceeded logically. First, because hypothesis testing regarding slopes are only
meaningful in the context of equal guessing parameters or asymptotes, the first comparison was
performed under the circumstances of assumed equality among c parameters across groups (as is
always the case under the 2PL). Likewise, testing for location parameter equality makes sense
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only under the condition of equivalent trace line slopes. Therefore, the assumption was that the a
parameters are equal when testing for b-DIF (Thissen, 2001; Thissen et al., 1993). In both cases,
the d.f. value was obtained by subtracting the number of parameters freely estimated in the
augmented model minus the freely estimated parameters in the compact model. Since each
successive model is nested with one additional parameter constrained to equality, for each model
comparison the d.f. value was one (Thissen et al., 1993).
These hierarchical model comparison IRT methods used in this study are sensitive to
sample size (Reeve, 2000). Due to this and the fact that multiple comparisons will be conducted,
a conservative alpha (α) of .01 will be used for all IRT DIF hypothesis testing to protect against
Type I error (Reeve, 2000; Teresi et al., 2000).
DIF interpretation. After the DIF detection process is complete, a final parameterization
can be run using MULTILOG 7.0 that incorporates any identified, significant DIF. As discussed
in Edelen et al. (2006), the resulting estimates can be used to aid in interpretation of the DIF.
DIF magnitude is visually inferred by placing the item ICCs corresponding to a positive response
for both groups on the same plot. Also, all item ICCs can be summed to create a separate test
response function (TRF) for both males and females. Placing each group’s TRFs on the same
plot allows a visual indication of the magnitude of the effect that the item-level DIF had on the
overall test total score. Excel can be used to create these plots using the 2PL equation.
External Evidence of Equivalent Validity by Gender
Logistic regression. Logistic regression was used to test whether the PC-PTSD was
differentially predictive of a later clinical PTSD diagnosis. This predictive validity analysis was
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performed multiple ways using various configurations of the PC-PTSD score as the IV: 1) a
continuous variable using the raw score (0 to 4), 2) a dichotomous variable indicating whether or
not the cutoff value of three was met, 3) a dichotomous cutoff of two, 4) a dichotomous cutoff of
one (the trigger for further evaluation and referral in the USAF), and 5) a dichotomous variable
using only the avoidance item (the avoidance-only screen). In each of these analyses, the DV
was the dichotomous indicator of clinical PTSD diagnosis status. Differential prediction for men
and women was assessed by testing for interactions between gender and each PC-PTSD scoring
method in each model predicting PTSD diagnosis status.
One additional regression analysis was conducted to assess the divergent validity of the
PC-PTSD. In this case the primary IV was the recommended PC-PTSD cutoff of three and the
DV was the dichotomous MDD diagnosis status variable. Depression was chosen for the
divergent validity comparison because it has been shown to be among the most highly comorbid
conditions with PTSD (Kessler et al., 1995).
Link function. The log-log link was chosen for these data due to the strong positive
skew of the frequency distribution of the PTSD status variable. Relatively few of the subjects
were diagnosed with PTSD, so the data contain far more zeros (denoting no PTSD diagnosis)
than ones (denoting the positive identification of PTSD). Under these circumstances, the log-log
model is preferable due to its asymmetrical density function and a probability function that
approaches one slowly while approaching zero rapidly. (Hardin & Hilbe, 2007; Simonoff,
2003). All regression analyses using the log-log model were conducted using the Stata 11.0
statistical program.
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Modeling procedure. For each of the six logistic regression analyses mentioned above,
the same modeling procedure was used as detailed in Orme and Combs-Orme (2009). Three IVs
were entered simultaneously: the PC-PTSD score as configured for that particular analysis and
sex as main effect IVs, and the cross-product of PC-PTSD score and sex as a moderator IV to
test for interaction. If the interaction was found to be significant, the analysis stopped and the
interaction was interpreted. If the interaction term was not significant, it was removed from the
model and the model was run again with only the appropriate PC-PTSD score main effect IV.
Significance level. As with the DIF portion of the study, the use of multiple analyses led
to concern for elevated risk of a Type I error. Therefore, a conservative alpha value of .01 was
chosen for all regression analyses. Although it was expected that any detected differential
prediction would result in an odds ratio for the interaction term that was greater than zero, twotailed significance tests were used because a result in either direction was deemed important. For
the same reason, two-tailed tests were used for any main effect models despite the expectation
that higher scores and met thresholds on the instrument would be positively related to either
diagnosis.
Model evaluation. Although there are no commonly accepted measures of overall model
fit for logistic regression comparable to R2 used in linear regression (Orme & Combs-Orme,
2009), each analyzed model was evaluated in a number of ways. Unstandardized deviance
residuals were examined to check for poor model fit at the case level. The Cook’s D (distance)
values were plotted to determine whether any outliers exerted undue influence on the results.
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Also, multicollinearity statistics were obtained on each model by running the model through
PASW 17.0 (formerly SPSS) linear regression (Orme & Combs-Orme, 2009).
Diagnostic utility. This analysis compared the diagnostic accuracy of the PC-PTSD in
identifying those that are at elevated risk for a PTSD diagnosis among both male and female
deployers. It is important to note that the term “diagnostic,” as used here in “diagnostic utility”
is only used to signify the type of analysis used. Strictly, the PC-PTSD screen can only identify
risk of PTSD or probable PTSD, not diagnose. Using the clinical PTSD diagnosis obtained from
the medical record database as the “gold standard,” the standard diagnostic utility statistics of
sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic
efficiency were calculated for each gender group. In addition, gender-specific positive and
negative diagnostic likelihood ratios were obtained.
Diagnostic criterion. The use of a clinical diagnosis not explicitly obtained using a
standardized, structured interview could be problematic. The reliability of psychiatric diagnoses
using unstructured interviews has long been questioned (Beck, Ward, Mendelson, Mock, &
Erbaugh, 1962) and structured diagnostic interviews have been shown to improve concordance
rates among providers (Helzer et al., 1977). Prins et al. (2003) compared the clinical provider
PTSD diagnosis obtained via examination of medical records to the gold standard of the CAPS
structured clinical interview. The clinically-derived diagnosis matched CAPS results—
indicating the subject was positive for PTSD—61% of the time while missing the diagnosis in
39% of cases. This equates to 61% sensitivity for the clinical diagnosis. MacGruder and
colleagues’ (2005) also used the CAPS with 745 veterans that agreed to a clinic interview out of
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a random sample of 1198 veterans having a minimum of one visit to primary care during 1999.
Medical record reviews yielded a sensitivity of 46.5% and specificity of 96.6% for the clinical
PTSD diagnosis compared to the CAPS research identification.
Despite these problems, Ouimette, Wade, Prins, and Schohn (2008) used a clinical
database similar to that proposed for use in the present study as the source for the reference
diagnosis in their study comparing the performance of two PTSD screens. Due to the limitations
of using this less reliable PTSD identification method, these researchers deemphasized findings
related to optimal cutoff values that could be compared to similar results in other studies.
Instead, they primarily analyzed the differences between the screens with regard to prediction of
PTSD. Likewise, the purpose of the proposed study was to compare the relative performance of
the PC-PTSD with males and females. The non-research, clinician diagnosis should therefore be
sufficient, though not optimal, for making this comparison.
Sensitivity and specificity. Sensitivity, also known as the true positive rate, is the
probability of those with the tested condition receiving a positive result on the test in question.
Specificity, on the other hand, consists of the proportion of examinees without the condition
manifesting a negative test result. Specificity is also known as the true negative rate (Akobeng,
2006a; Baldessarini, Finklestein, & Arana, 1983).
Predictive values. Predictive values are used to provide the probability that the results of
the test directly correspond with the actual diagnostic status. Positive predictive value (PPV) is
found by dividing the number of true positives by all those who tested positive for the condition.
Negative predictive value (NPV) is similarly calculated with the true negatives in the numerator
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and the total of those testing negative in the denominator (Akobeng, 2006a; Baldessarini et al.,
1983).
Diagnostic efficiency. A related statistic, diagnostic efficiency or power, can also be
calculated by dividing the combined true positive and true negative outcomes by the total of all
of those tested. However, this statistic tends to overestimate a given test’s power (Baldessarini et
al., 1983).
Diagnostic likelihood ratio. While PPV and NPV are important indicators of test
performance, they will vary according to the prevalence of the condition in a particular
population (Akobeng, 2006a). Alternatively, a diagnostic likelihood ratio (DLR) can be obtained
that combines both sensitivity and specificity (Akobeng, 2006b). This measure has a couple of
important advantages. The first is that the DLR is independent from the prevalence of a
condition within a population (Furukawa & Goldberg, 1999; Furukawa, Goldberg, RabeHesketh, & Ustun, 2001; Pepe, 2003; Zhou, Obuchowski, & McClish, 2002). Pepe (2003)
explains that this independence is derived from the fact that the DLR is merely a function of
probabilities for diagnostic classification. A second advantage involves reduced sensitivity to
variation in population factors such as comorbidity and severity of the index condition
(Furukawa & Goldberg, 1999; Furukawa et al., 2001). This was a useful property for the current
study because, as mentioned in the above literature review, comorbidity was speculated to be a
factor in the observed gender difference in diagnostic efficiency reported in the Prins et al.
(2003) PC-PTSD validation study. Within the research context, the DLR measure has previously
been used to compare the relative diagnostic utility of a screen across populations (Furukawa,
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Andrews, & Goldberg, 2002), between two PTSD screens within a single population (Ouimette
et al., 2008), and between two versions of the same health screen across multiple care centers
(Furukawa et al., 2001).
Also, in clinical practice DLRs can be combined with population-specific prevalence
information (also known as the pre-test probability of having the condition) using a
straightforward procedure in order to estimate post-test probabilities to aid clinicians in the
diagnostic decision process (Akobeng, 2006b; Sackett & Straus, 1998). This approach is more
common among medical providers than among behavioral health providers. However, as
mentioned above, a positive PC-PTSD screen in the USAF can result in referral to either type of
clinician.
Likewise, the raw value of the DLR can be helpful in interpreting the results for a
particular respondent. For instance, a DLR for a positive test with a value greater than 10
indicates a high likelihood that that tested condition is present in a respondent that tests positive.
Conversely, if the DLR for a positive test is less than 0.1, a respondent who has tested positive is
very unlikely to have the index condition (Akobeng, 2006b; Ouimette et al., 2008).
There are two types of DLRs: the likelihood ratio for a positive test (DLR+) and the
likelihood ratio for a negative test (DLR-). The DLR+ is defined as the probability of a person
with the index condition testing positive divided by the probability of a person without the
condition testing positive. In similar fashion, the DLR- is the probability of a person with the
condition testing negative divided by the probability of a person without the condition receiving
a negative test result (Akobeng, 2006b,). Both formulae are given as follows:
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Once the DLRs were obtained for both males and females under each tested PC-PTSD
cutoff score and the single-item avoidance screen, the corresponding male and female DLRs
were tested to determine whether they were significantly different from one another. This was
accomplished using confidence intervals (CI), which are calculated as follows for both DLRs:
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where Sens and Spec represent sensitivity and specificity, respectively, and z is the (1 - α/2)th
percentile of the standard normal distribution (Zhou et al., 2002). For the DLR+ CI, s1 stands for
the number of true positives and r1 is the number of false positives. For the DLR- CI, s0
corresponds to the number of false negatives and r0 denotes the number of true negatives.
Again, a conservative p-value of .01 was used to protect against the increased risk of
Type I error inherent with multiple comparisons. Since the DLR is theoretically independent of
prevalence, if the 99% CI shows that a particular set of male/female DLRs are statistically
significantly different, this would be another indication that the PC-PTSD is performing
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differently based on gender. All diagnostic utility statistics were computed using Microsoft
Excel.
Procedure. The gender-specific diagnostic utility statistics were calculated for cutoffs of
one, two, three, and four, as well as for the single item avoidance screen suggested by Bliese et
al. (2008). This analysis used the same sample as that used in the logistic regression analyses
above. Separate cross tabulations were created for both sexes comparing each studied
dichotomous cutoff score of the PC-PTSD with PTSD diagnostic status. This resulted in a total
of ten contingency tables (five per gender) that supplied the data necessary for calculating all of
the required diagnostic utility statistics.
Validity using CFA.
The final analysis examined the convergent and divergent validity of the PC-PTSD using
CFA. This analysis did not assess for any gender differences in the PC-PTSD, but instead
examined the overall validity of the PC-PTSD with a large group of the target population for the
PDHRA screening: returning USAF deployers. A two-factor model was tested with the four
PC-PTSD items loading on one factor (Factor 1 - PTSD) and the two-item depression screen
used in the PDHRA loading on the other factor (Factor 2 – depression). Due to the high
comorbidity of PTSD and depression (Kessler et al., 1995), Factors 1 and 2 were allowed to
correlate in the model. As in the logistic regression analysis, depression was chosen as the
criterion for measuring discriminant validity due to the high comorbidity between that diagnosis
and PTSD.

93
The sample for the CFA analysis (N = 6963; males = 5756, females = 1207) was a subset
of the sample used for the logistic regression and diagnostic utility analyses (N = 6999). The
slightly smaller sample size was the result of 36 cases from the larger sample with missing
values on at least one of the two depression queries (0.5%).
Depression screen. The two-item depression screen used in the PDHRA consists of two
items from the Patient Health Questionnaire (PHQ; Spitzer, Kroenke, & Williams, 1999). The
screen as implemented in the PDHRA asks, “Over the past month, have you been bothered by
the following problems?” The two items are, “Little interest or pleasure in doing things,” and
“Feeling down, depressed, or hopeless.” Responses to each item are given on a four-category
Likert scale (“Not at all,” “Few or several days,” “More than half the days,” or “Nearly every
day”). These responses were respectively scored 0, 1, 2 and 3.
The two-item PHQ has been shown to have favorable diagnostic characteristics in a
couple of validation studies with relatively large sample sizes (Arroll, Goodyear-Smith, Kerse,
Fishman, & Gunn, 2005; Whooley, Avins, Miranda, & Browner, 1997). In fact, Whooley et al.
(1997) demonstrated that this two-question screen performed about as well at detecting
depression as accepted depression questionnaires with many more items, including the
abbreviated versions of the Beck Depression Inventory (BDI; Beck & Beck, 1972) and the
Center for Epidemiologic Studies Depression Scale (CES-D; Andersen, Malmgren, Carter, &
Patrick, 1994). The purpose of including this brief depression scale in the CFA analysis is not to
validate yet another screen included in the PDHRA. Rather, the two-item PHQ is included in the
model in order to aid in the testing of convergent and divergent validity within the PC-PTSD.
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Procedure. The CFA analysis was conducted using Mplus 4.0 (Muthen & Muthen,
2006). All path weights were freely estimated, no error terms were allowed to correlate, and the
variance of both latent factors was fixed at a value of 1 in order to fix their metric. Also, no
cross-loadings were permitted. Robust weighted least squares is the default estimator for CFA
involving factor indicators with categorical responses in Mplus, and this option was left
unchanged for this analysis. Also, as is appropriate for dichotomous and polytomous indicators,
tetrachoric or polychoric correlation methods were used (Brown, 2006; Muthen & Muthen,
2004).
Model fit was evaluated using both the root mean square error of approximation
(RMSEA) and the comparative fit index (CFI). Recommendations for the RMSEA provide
information at multiple levels: Values of .06 or lower are indicative of a well-fitting model with
large samples, around .08 indicates a medium degree of fit, and .10 or higher suggests less than
adequate fit. For the CFI, good fit is indicated by values near or above .95 (Byrne, 2001).
Convergent validity was assessed by examining the extent to which the indicators loaded
onto the expected factors. Divergent or discriminant validity was judged using the correlation
between the latent factors. Discriminant validity is considered adequate when this correlation is
less than or equal to .80 (or .85) (Brown, 2006). A conventional α = .05 was used to determine
whether estimates were significantly different from zero.
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CHAPTER IV: RESULTS
Sample Characteristics
Each of the three samples used in this study were analyzed to determine the degree to
which the male and female comparison groups were similar on available background
characteristics. For continuous characteristic variables an independent samples t-test was used as
implemented in PASW. With categorical variables, in most cases the analyses were performed
using Pearson’s chi-square independence test (also within PASW). However, there were some
tables larger than two-by-two that contained cells with expected frequency values that were
smaller than five. In such instances, the SAS program was used to conduct Fisher’s exact test.
Due to the large sample sizes and alpha level of .01 was chosen. All probabilities were twotailed.
IRT DIF Sample
All the results of the sample characteristic comparisons are included in Table 1. Within
this sample, there were no differences detected between men and women with regard to the
number of months they were deployed, the deployment location (Iraq, Afghanistan, or both), or
the categories of rank which they had attained (enlisted, officer, or other). However, several
statistically significant differences were detected. Males had higher mean age (M = 30.88, SD =
7.82; t(9806) = 4.85, p < .001) than females (M = 29.82, SD = 7.56), as well as a larger mean
total number of deployments (M male = 1.87, SD = 1.42; Mfemale = 1.45, SD = 1.14; t(9806) =
12.16, p < .001). Also, the mean number of days between the return from deployment and
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Table 1
Sample Characteristics for the Differential Item Functioning Sample
Characteristic Variables

Males (N = 8381)

Females (N = 1425)

Age (mean ± SD)

30.88 ± 7.82

29.82 ± 7.56

t(9806) = 4.85, p < .001

Months deployed (mean ± SD)

5.90 ± 3.79

5.75 ± 2.65

t(9806) = 1.84, p = .066

Total number of deployments (mean ± SD)

1.87 ± 1.42

1.45 ± 1.14

t(9806) = 12.16, p < .001

119.68 ± 24.72

117.18 ± 23.72

t(9806) = 3.60, p < .001

Days between deployment and screen (mean ± SD)

χ2(2, N = 9806) = 2.87, p = .238

Deployment location, N (%)
Iraq

6273 (74.8)

1070 (75.1)

Afghanistan

1984 (23.7)

342 (24.0)

124 (1.5)

13 (.9)

Both
Marital status at time of screening, N (%)

p < .001, Fisher’s exact test

Never married

2475 (29.5)

478 (33.5)

Married

5199 (62.0)

658 (46.2)

Separated

51 (.6)

19 (1.3)

Divorced

650 (7.8)

268 (18.8)

Widowed

6 (.1)

2 (.1)
χ2(2, N = 9803*) = 6.56, p = .038

Rank category, N (%)
Enlisted

7001 (83.6)

1152 (80.9)

Officer

1344 (16.0)

267 (18.8)

34 (.4)

5 (.4)

Other
Military status prior to deployment, N (%)
Active duty

p < .001, Fisher’s exact test
7384 (88.1)

1329 (93.3)

Reserve

144 (1.7)

20 (1.4)

National Guard

717 (8.6)

70 (4.9)

Civilian

119 (1.4)

5 (.4)

17 (.2)

1 (.1)

Other
Note. N = 9806. All p are two-tailed. SD = standard deviation.
*Missing data in rank field for 3/9806 cases (.03%).

Test Results
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the completion of the PDHRA screen was somewhat higher for men (M = 119.68, SD = 24.72;
t(9806) = 3.60, p < .001) than women (M = 117.18, SD = 23.72). Statistically significant
differences were also found for marital status at the time of taking the screen (p < .001, Fisher’s
exact test), with the largest disparities occurring those identifying themselves as married (62.0%
for men compared to 46.2% of women) and divorced (18.8% among women and 7.8% of men).
Women also tended to more often identify their military status prior to their deployment (p <
.001, Fisher’s exact test) as “active duty” (93.3% compared to 88.1% of men) while men had a
higher proportion of national guard (8.6% vs. 4.9% among females).
These results indicate that the male and female comparison groups were not equivalent
on certain background characteristics. It is likely, however, that the identified statistically
significant differences have varying levels of practical significance—especially considering the
large sample size. For example, when the average number of days between returning from
deployment and completing the post-deployment screening approaches four months for both
genders, it is not clear whether an average difference of less than three days would have much
actual impact on PC-PTSD responses. In contrast, the marital status differences appear much
more substantial with the proportion of divorced women being more than double the proportion
of divorced men.
Regression and Diagnostic Utility Sample
See Table 2 for detailed information on each sample characteristic variable. All
background variables for this sample were the same as for the IRT sample, except for one. Since
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Table 2
Sample Characteristics for the Logistic Regression/Diagnostic Utility Sample
Characteristic Variables

Males (N = 5785)

Females (N = 1214)

Age (mean ± SD)

30.63 ± 7.44

29.68 ± 7.49

t(6999) = 2.90, p = .004

Months deployed (mean ± SD)

6.24 ± 4.03

5.89 ± 2.63

t(6999) = 3.75, p < .001

Total number of deployments (mean ± SD)

1.84 ± 1.39

1.41 ± 1.11

t(6999) = 11.72, p < .001

Days between deployment and screen (mean ± SD)

118.00 ± 23.52

116.19 ± 23.39

t(6999) = 2.44, p = .015

Days between screen and diagnostic visit (mean ± SD)

53.35 ± 27.50

60.70 ± 25.06

t(6999) = -9.14, p < .001
χ2(2, N = 6999) = 3.26, p = .196

Deployment location, N (%)
Iraq

4338 (75.0)

917 (75.5)

Afghanistan

1361 (23.5)

287 (23.6)

86 (1.5)

10 (.8)

Both
Marital status at time of screening, N (%)

p < .001, Fisher’s exact test

Never married

1693 (29.3)

395 (32.5)

Married

3589 (62.0)

572 (47.1)

Separated

43 (.7)

16 (1.3)

Divorced

457 (7.9)

230 (18.9)

Widowed

3 (.1)

1 (.1)
χ2(2, N = 6998*) = 7.25, p = .027

Rank category, N (%)
Enlisted

4856 (83.9)

981 (80.9)

Officer

902 (15.6)

227 (18.7)

27 (.5)

5 (.4)

Other
Military status prior to deployment, N (%)
Active duty

p = .703, Fisher’s exact test
5642 (97.5)

1193 (98.3)

Reserve

40 (.7)

7 (.6)

National Guard

90 (1.6)

13 (1.1)

Civilian

10 (.2)

1 (.1)

Other

3 (.1)

0 (0.0)

Note. N = 6999. All p are two-tailed. SD = standard deviation.
*Missing data in rank field for 1/6999 cases (.01%).
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this sample was the only sample used to compare the screen results to a diagnosis obtained
during a clinical medical visit, a variable was added totaling the days between the date of the
screen and the date of the diagnostic visit.
Similar to the IRT sample, of which this sample was a subset, no statistically significant
differences were identified between groups of men and women on deployment location or rank
classification. One difference, though, was that in this sample no difference was detected across
gender with respect to the mean number of days between returning from deployment and the
screening date. On average, though, males spent more months deployed (M male = 6.24, SD =
4.03; Mfemale = 5.89, SD = 2.63; t(6999) = 3.75, p < .001), which was also a change from the IRT
sample. Men also tended to be older (Mmale = 30.63, SD = 7.44; Mfemale = 29.68, SD = 7.49;
t(6999) = 2.90, p = .004), and to have been deployed more often (Mmale = 1.84, SD = 1.34; Mfemale
= 1.41, SD = 1.11; t(6999) = 11.72, p < .001). Women, on the other hand, had a higher mean
number of days between screen completion and the diagnostic medical visit (Mfemale = 60.70, SD
= 25.06; t(6999) = -9.14, p < .001) when compared to men (Mmale = 53.35, SD = 27.50). There
was again a statistically significant relationship between gender and marital status (p < .001,
Fisher’s exact test), with males more likely to be married (62.0% of men; 47.1% of women) and
females more likely to be divorced (18.9% among women and 7.9% of men).
An interesting difference between this sample and the IRT sample is that in this instance
no statistically significant relationship was detected between gender and military status prior to
deployment (p = .703, Fisher’s exact test). A closer inspection of the proportions in each
category for both samples reveals that the percentage of male and female in the active duty
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classification increased from that in the IRT sample (93.3% and 88.1%, respectively) to around
98% for both genders (97.5% for men; 98.3% for women) in the current sample. This change in
proportion probably occurred because of the requirement that all cases in the
regression/diagnostic utility sample have a military medical diagnostic visit within 90 days after
the date of the PDHRA screen. Immediately after deployment, most non-active duty members of
the military return to local communities that may or may not be near a military facility large
enough to have military medical services. For example, while an Air National Guard base may
have some limited medical capabilities, many of the guard members attached to that base tend to
reside hours from the installation and typically only come to the base one weekend per month.
This is in contrast to active duty military personnel who, after deployment, almost exclusively
return to live locally at or near a military base that houses its own military medical facility. It is
therefore likely that non-active duty subjects had a much lower frequency of attaining military
medical care in the 90 days after the PDHRA screen, and so were disproportionately excluded
from this sample.
CFA Sample
Table 3 contains the gender breakdown of the sample characteristics for the CFA sample.
The pattern of background differences (and lack of differences) that emerged across gender
groups for this sample was the same as that found for the regression/diagnostic utility sample.
This was expected, to some extent, because the CFA sample was attained by removing 36 cases
from the former sample due to missing responses on the depression screen used in the CFA
analysis. As in the regression/diagnostic utility sample, no statistically significant differences
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Table 3
Sample Characteristics for the Confirmatory Factor Analysis Sample
Characteristic Variables

Males (N = 5756)

Females (N = 1207)

Age (mean ± SD)

30.35 ± 7.43

29.69 ± 7.49

t(6963) = 2.80, p = .005

Months deployed (mean ± SD)

6.23 ± 4.03

5.90 ± 2.63

t(6963) = 3.58, p = .000

Total number of deployments (mean ± SD)

1.84 ± 1.39

1.41 ± 1.11

t(6963) = 11.58, p = .000

118.02 ± 23.50

116.14 ± 23.38

t(6963) = 2.53, p = .012

Days between deployment and screen (mean ± SD)

χ2(2, N = 6963) = 2.85, p = .241

Deployment location, N (%)
Iraq

4318 (75.0)

911 (75.5)

Afghanistan

1355 (23.5)

286 (23.7)

83 (1.4)

10 (.8)

Both
Marital status at time of screening, N (%)

p < .001, Fisher’s exact test

Never married

1685 (29.3)

392 (32.5)

Married

3570 (62.0)

570 (47.2)

Separated

43 (.7)

16 (1.3)

Divorced

455 (7.9)

228 (18.9)

Widowed

3 (.1)

1 (.1)
χ2(2, N = 6962*) = 7.76, p = .021

Rank category, N (%)
Enlisted

4832 (84.0)

974 (80.8)

Officer

897 (15.6)

227 (18.8)

27 (.5)

5 (.4)

Other
Military status prior to deployment, N (%)
Active duty

p = .586, Fisher’s exact test
5615 (97.6)

1187 (98.3)

Reserve

38 (.7)

7 (.6)

National Guard

90 (1.6)

12 (1.0)

Civilian

10 (.2)

1 (.1)

Other

3 (.1)

0 (0.0)

Note. N = 6963. All p are two-tailed. SD = standard deviation.
*Missing data in rank field for 1/6963 cases (.01%).

Test Results

102
were uncovered between males and females on the average number of days between the return
from deployment and the screen date, the location of deployment, rank category, or military
status before deployment. Observed gender differences did rise to statistical significance with
regard to age (Mmale = 30.35, SD = 7.43; Mfemale = 29.69, SD = 7.49; t(6963) = 2.80, p = .005),
months deployed (Mmale = 6.23, SD = 4.03; Mfemale = 5.90, SD = 2.63; t(6963) = 3.58, p = .000),
total number of deployments (Mmale = 1.84, SD = 1.39; Mfemale = 1.41, SD = 1.11; t(6963) =
11.58, p = .000), and marital status (p < .001, Fisher’s exact test).
Measurement Equivalence by Gender
Prior to detailing the findings of this analysis, the presentation will begin with the results
of the assumption testing and model fit analyses. This will be followed by the search for suitable
anchor items.
Model Fit Analyses
Model comparison. The nested model comparison between fitting the 2PL versus the
1PL to the data was statistically significant (G2(4) = 36.3, p < .001). This indicated that, in a
relative sense, the 2PL fit the data better than the 1PL. As expected, a similar comparison
between the 3PL and 2PL models was not statistically significant (G2(4) = 2.3, p = .681),
meaning that fitting the 3PL to the data did not result in a significantly better fit than the 2PL.
Therefore, the 2PL model was used in all subsequent IRT analyses of the study data.
Item fit. Using alpha equal to .05, two-tailed, the item fit analysis using IRTFIT
(Bjorner et al., 2007) indicated misfit for two items: item 2/avoidance (S-χ2(1) = 3.92, p = .048)
and item 3/arousal (S-χ2(1) = 8.17, p = .004). Items 1 and 4, corresponding respectively to
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reexperiencing and numbing symptoms, showed adequate fit (item 1: S-χ2(1) = 3.73, p = .054;
item 4: S-χ2(1) = 1.32, p = .250). However, at this level of α item 1 was very near to exhibiting
lack of fit. These results suggested that the 2PL model does not fit well with these data (at least
for two of the items).
As pointed out in Orlando and Thissen (2000), the sensitivity of this chi-square statistic
is likely to increase with larger samples. Since their study was conducted with a sample size of
1000, however, it was unclear to what degree this sensitivity would have affected the item fit
analysis results of the current study (N = 9806). To date, this statistic has yet to be tested in a
simulation study with sample sizes in this range (M. O. Edelen, personal communication, April
26, 2010). Although the lack of fit indicated by the item fit analysis is a concern, the possibility
cannot be ruled out that the statistic is oversensitive to misfit—that is, identifies miniscule
inconsistencies as problematic—at this sample size. Using an alpha level of .01 to attempt to
account for the effect of sample size resulted in an indication of misfit for only item 3.
Assumption Testing
Only the unidimensionality assumption was explicitly tested. As detailed in the chapter
on methods, the assumption of local independence is satisfied if the unidimensionality
assumption is met. Also, the invariance assumption was not assessed because there is no general
test for parameter estimate invariance.
The EFA using tetrachoric correlations was indicative of unidimensionality in the PCPTSD response data. Eigenvalues were obtained from the inter-item tetrachoric correlation
matrix. The first eigenvalue (3.37) was much larger than the remaining three (.27, .25, .11),
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which constitutes evidence consistent with single-factor dominance and, therefore,
unidimensionality (Hambleton et al., 1991; Lord & Novick, 1968). The scree plot of the
eigenvalues can be inspected in Figure 2.
Anchor Identification
Regression method. The standardized residuals resulting from the regression of
separately estimated male and female parameters onto one another indicated that items 3
(arousal) and 4 (numbing) were likely candidates to serve as anchors during the IRT DIF
procedure. Item 4 had the lowest standardized residual for the a parameter (.29) while that for
item 3 was lowest among all the b parameters (.30).
Conversely, items 1 (reexperiencing) and 2 (avoidance) were identified as suspected DIF
items given their relatively high standardized residuals. The highest a parameter standardized
residual was observed on item 1 (1.00) and the highest b parameter residual occurred on item 2
(1.02). Therefore, Flannery and colleagues’ (1995) anchor-identification method suggested that
items 3 and 4 should comprise the anchor for this DIF analysis, with items 1 and 2 the targets of
the analysis. As mentioned previously, throughout the remainder of the IRT DIF analysis the
working assumption will be that the anchor items are free of DIF.
Graphical method. Next, the separate a and b parameter estimates for each gender
group were plotted against one another. Item 1 had the greatest deviation from the fit line on the
plot for a, while item 4 was the closest to the same fit line. Likewise, on the b plot item 2 was
the most deviant from the fit line and item 3 was the least. Thus, items 3 and 4 were
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Figure 2. Scree plot of the eigenvalues for testing the unidimensionality assumption with the
sample used for IRT DIF analysis.
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recommended as anchors and items 1 and 2 are candidates for DIF. These results confirmed
those obtained using the regression method.
IRT DIF Results
MULTILOG initially failed to achieve convergence in its estimation of the item
parameters for this analysis, yielding unexpected negative chi-square difference values for G2.
However, convergence was achieved by raising the maximum number of estimation cycles in the
program.
As noted in Table 4, no significant DIF was detected in either items 1 or 2 of the PCPTSD using the model comparison method. In the likelihood ratio comparison of Model 2 and
Model 1 assessing DIF in the a parameters for both items 1 (G2(1) = 0, p = 1.000) and 2 (G2(1) =
0, p = 1.000), the null hypothesis of no DIF could not be rejected. Similarly, the analyses for b
parameter DIF also did not allow for rejection of the null hypothesis (item 1: G2(1) = .1, p =
.752; item 2: G2(1) = 0, p = 1.000).
External Evidence of Equivalent Validity by Gender
Logistic Regression
In all logistic regression models, males were coded as 0 and females were coded as 1.
Before summarizing the logistic regression results, the discussion begins with a review of the
model evaluation analyses.
Model evaluation. According to Menard (2002), when assessing model fit a researcher
should be concerned about unstandardized deviance residual values with an absolute value
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Table 4
Item Parameters for Male and Female Subgroups on the PC-PTSD
Males
Item

Content

Tests for DIF: G2 (p)

Females

a(SE)

b(SE)

a(SE)

b(SE)

a-DIF

b-DIF

Suspected DIF items
1

Reexperiencing

3.99 (0.23)

1.51 (0.03)

4.02 (0.48)

1.52 (0.06)

0 (1.000)

.1 (.752)

2

Avoidance

5.13 (0.37)

1.59 (0.03)

5.37 (0.78)

1.58 (0.05)

0 (1.000)

0 (1.000)

Anchor items
3

Arousal

3.03 (0.13)

1.45 (0.03)

3.03 (0.13)

1.45 (0.03)

--

--

4

Numbing

3.26 (0.17)

1.61 (0.03)

3.26 (0.17)

1.61 (0.03)

--

--

Note. For anchor items, each parameter constrained to equality across males and females. N = 9806 (Males = 8381,
Females = 1425). Each value of G2 given is at one degree of freedom. PC-PTSD = Primary Care Posttraumatic
Stress Disorder screen; DIF = differential item functioning; a = the item difficulty or location parameter; b = the
item discrimination or slope parameter; SE = standard error.
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greater than 2 and, especially, 3. If Cook’s D is larger than 1, an outlying case may be exerting
undue influence on the regression coefficient (Orme & Combs-Orme, 2009). Finally, a couple of
indicators of problematic multicollinearity among the IVs were used: tolerance and the variance
inflation factor (VIF). Tolerance is indicative of possible multicollinearity problems at values
lower than .1 (Norusis, 2006; Orme & Combs-Orme, 2009). The threshold indicating
problematic multicollinearity for VIF, on the other hand, is for values greater than 10 (Orme &
Combs-Orme, 2009).
Inspection of residuals. Among the five regression analyses using PTSD diagnosis as
the DV, all five had some unstandardized deviance residuals that were just above 3. In each
instance, the cases in question were those where the particular PC-PTSD score for that analysis
equaled zero but the PTSD diagnosis variable equaled 1. This is, perhaps, not surprising given
that just having the PTSD diagnosis variable equal to 1 was very unusual in this sample. Also, as
will be discussed in the next section, the PC-PTSD score significantly predicted a PTSD
diagnosis. This means that it would be even more unusual, in this sample, for a subject to be
diagnosed with PTSD but not have that risk reflected in their PC-PTSD score.
Analysis 1 (total PC-PTSD score) and Analysis 4 (cutoff ≥ 1) both had cases with
unstandardized residuals higher than 2 (but lower than 3). Again, in both instances the PTSD
diagnosis variable equaled 1. The cases in this range for Analysis 1 were those where the total
PC-PTSD score was either 1 or 2. For Analysis 4, these were the cases where cutoff ≥ 1 was
scored 1. Again, since positive responses to both of these variables were relatively scarce in this
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sample (the great majority of scores on both were zero), these would be unusual cases in the
model.
The model that used MDD diagnosis as the DV, Analysis 6 (cutoff ≥ 3), also had
unstandardized deviance residuals higher than the thresholds of 3 and 2. The pattern was similar
to that found in the other analyses. Cases scored at 0 for cutoff ≥ 3 and 1 for MDD diagnosis had
residuals above 3, whereas cases with both cutoff ≥ 3 and MDD diagnosis equal to 1 exhibited
residuals in the range of 2 to 3.
Cook’s D. No case in any of the analyses had a Cook’s D that approached 1.0. In fact,
the highest value among all analyses was .05. For all but one analysis, the highest strata of
Cook’s D values corresponded to the same cases that were associated with unstandardized
deviance residuals greater than 3. The exception was Analysis 6, for which the highest Cook’s D
values were those associated with residuals between 2 and 3.
Multicollinearity. Inspection of the tolerance and VIF values revealed that there were no
problems with excessive multicollinearity. Of course, multicollinearity diagnostics were only
run for models that included more than one IV.
Results of analyses. Table 5 details the interaction models for each of the six analyses.
Table 6 summarizes the main effect models. The final model in both tables is the divergent
validity regression analysis using MDD rather than PTSD as the DV.
Interaction models. As is shown in Table 5, within each analysis the overall interaction
model was statistically significant as indicated by the omnibus likelihood ratio test. However,
none of the interaction terms in the initial models for each analysis were statistically significant.
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Table 5
Interaction Analyses of the PC-PTSD Using Log-Log Regression
Independent Variables
Analysis 1

Dependent Variable

Odds Ratio

z

PTSD

381.97 @ 3 d.f.***

Total PC-PTSD

1.54

Sex

1.09

1.09

Total PC-PTSD X Sex

.93

-1.38

Analysis 2

15.26***

PTSD

245.38 @ 3 d.f.***

Cutoff ≥ 3

3.31

12.19***

Sex

1.05

.68

Cutoff ≥ 3 X Sex

.97

-.15

Analysis 3

PTSD

308.63 @ 3 d.f.***

Cutoff ≥ 2

2.91

14.44***

Sex

1.04

.51

Cutoff ≥ 2 X Sex

.97

-.22

Analysis 4

PTSD

307.80 @ 3 d.f.***

Cutoff ≥ 1

2.65

Sex

1.17

1.67

Cutoff ≥ 1 X Sex

.84

-1.23

Analysis 5

14.58***

PTSD

225.82 @ 3 d.f.***

Avoidance item

2.88

Sex

1.09

1.23

Avoidance X Sex

.88

-.74

Analysis 6

Likelihood Ratio Test

12.46***

MDD

37.26 @ 3 d.f.***

Cutoff ≥ 3

1.72

4.11***

Sex

1.32

3.50***

Cutoff ≥ 3 X Sex

.96

-.16

Note. Males coded as 0, females coded as 1. Odds ratio obtained from exp(B) in output for given model. N = 6999 (Males = 5785, Females =
1214). PC-PTSD = Primary Care Posttraumatic Stress Disorder screen; X = cross for crossproduct interaction term; d.f. = degrees of freedom.
***p<.001
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Table 6
Main Effect Analyses of the PC-PTSD Using Log-Log Regression
Scoring Method

Odds Ratio (99% CI)

z

Likelihood Ratio Test

Total PC-PTSD

1.52 (1.42-1.61)

17.14***

379.86 @ 1 d.f.***

Cutoff ≥ 3

3.30 (2.66-4.10)

14.15***

244.92 @ 1 d.f.***

Cutoff ≥ 2

2.90 (2.45-3.42)

16.46***

308.37 @ 1 d.f.***

Cutoff ≥ 1

2.56 (2.20-2.97)

16.16***

305.14 @ 1 d.f.***

Avoidance item

2.80 (2.32-3.38)

14.04***

224.29 @ 1 d.f.***

1.72 (1.31-2.26)

5.14***

24.29 @ 1 d.f.***

DV: PTSD diagnosis

DV: MDD diagnosis
Cutoff ≥ 3

Note. Males coded as 0, females coded as 1. Odds ratio obtained from value of exp(B) in
statistical program output for given model. N = 6999 (Males = 5785, Females = 1214). PCPTSD = Primary Care Posttraumatic Stress Disorder screen; CI = confidence interval; DV =
dependent variable; d.f. = degrees of freedom.
***p<.001
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This indicates that no interactions were detected between PC-PTSD score and gender. Thus,
there was no evidence that the PC-PTSD was differentially predicting subsequent PTSD for
males versus females. This was true for all configurations of PC-PTSD score.
Main effect models. Since no interactions were found, each analysis was modeled again
using only the PC-PTSD score as a predictor variable. As can be seen in Table 6, the omnibus
test for each main effect model was statistically significant.
Analysis 1. This analysis found that the total PC-PTSD score was significantly related in
the predicted direction to whether or not a clinical PTSD diagnosis was given within 90 days of
the screening. With each one point increase in the PC-PTSD score, the odds of being diagnosed
with PTSD increase by 52% (OR = 1.52, z(6999) = 17.14, p < .001).
Analysis 2. Using the recommended cutoff of three or more positive responses was also
predictive of a PTSD diagnosis. Returning USAF Iraq and Afghanistan deployers meeting this
cutoff had more than three times the odds of receiving a PTSD diagnosis (OR = 3.30, z(6999) =
14.15, p < .001) compared to subjects not meeting the cutoff.
Analysis 3. An alternative cutoff of two or more positive PC-PTSD responses was
likewise effective in predicting PTSD. The odds of a PTSD diagnosis nearly tripled (OR = 2.90,
z(6999) = 16.46, p < .001) for those meeting a cutoff of 2 when compared to those who did not.
Analysis 4. The predictor for this analysis was a PC-PTSD cutoff of one or more positive
responses. This is the “real world” scoring method used by the USAF to trigger a referral for
further assessment. As with the previous scoring methods, this minimal cutoff was significantly
related to a subsequent PTSD diagnosis. Answering “Yes” to at least one item on the PC-PTSD
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resulted in more than two-and-a-half times the odds of being clinically diagnosed with PTSD
(OR = 2.56, z(6999) = 16.16, p < .001), as opposed to answering “No” on all four items.
Analysis 5. The last analysis using the PC-PTSD score to predict clinical PTSD involved
the use of the single-item screen suggested by Bliese et al. (2008). Once again, a positive
response to the PC-PTSD avoidance question (item 3) was an effective predictor of later PTSD
status. The odds of a PTSD diagnosis were nearly three times higher for Iraq and Afghanistan
veterans answering “Yes” on this item (OR = 2.80, z(6999) = 14.04, p < .001) than for veterans
selecting “No.”
As expected from previous validation studies, among the dichotomous IVs, the cutoff
value of 3 was the most predictive of a subsequent PTSD diagnosis. Also, the single-item screen
was nearly as predictive of PTSD as the cutoff of 2, and was better at predicting PTSD than the
cutoff of 1.
Divergent validity. Analysis 6 was included to provide an indication of whether the PCPTSD was more effective at predicting PTSD than MDD, which, as delineated previously, is
highly comorbid with PTSD. For this analysis, the recommended PC-PTSD cutoff of 3 was
modeled with MDD status as the DV. The results were that, at this cutoff level, the PC-PTSD
was able to significantly predict a subsequent clinical MDD diagnosis. Satisfying the cutoff of 3
was associated with 1.7 times higher odds of an MDD diagnosis (OR = 1.72, z(6999) = 5.14, p <
.001) compared to not meeting the cutoff.
Analysis 2 modeled the same PC-PTSD score configuration using the identical sample.
The only difference between the main effect models in Analysis 2 and Analysis 6 was the DV:
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Analysis 2 modeled PTSD and Analysis 6 modeled MDD. It appears that at the cutoff level of 3,
the PC-PTSD was better at predicting PTSD (OR = 3.30) than MDD (OR = 1.72). However, it is
unclear whether the difference between these ORs rises to the level of statistical significance.
The CFA results later in this chapter will attempt to address the same divergent validity issue
within a single model.
Diagnostic Utility
Differential prediction. The results of the diagnostic utility analyses are summarized in
Table 7. Although the DLR+ was higher for males on each tested PC-PTSD scoring method,
none of these differences were statistically significant. As Table 7 shows, none of the 99%
confidence intervals overlapped between the male and female respondent groups. The pattern
for whether men or women had the lowest DLR- was more variable than with the DLR+ gender
differences. However, all differences were likewise statistically insignificant. This outcome was
consistent with that of the logistic regression portion of the study in providing no evidence for
differential prediction of PTSD by gender for the PC-PTSD.
Predictive value. Each tested PC-PTSD configuration was found to have some value in
predicting later PTSD. This was demonstrated by the fact that none of the CIs for the DLRs were
inclusive of the value of 1, and that all DLR+ values were greater than 1 and all DLR- values
were less than 1. For example, a DLR+ equal to 1 indicates that those with and without the index
disorder have an equal probability of testing positive on the instrument. If the DLR+ value is
lower than 1, subjects with the disorder actually have a lower probability of testing positive on
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Table 7
Comparison of PC-PTSD Diagnostic Utility by Gender
Cutoff

Sensitivity

Specificity

Efficiency

PPV

NPV

DLR+ (99% CI)

DLR- (99% CI)

Male

.85

.89

.89

.10

1.00

7.56 (8.77-6.52)

.16 (.32-.08)

Female

.78

.84

.84

.10

.99

4.83 (6.56-3.56)

.26 (.65-.10)

Male

.68

.94

.94

.16

.99

12.55 (15.86-9.94)

.33 (.50-.22)

Female

.75

.91

.91

.17

.99

8.47 (12.27-5.85)

.27 (.64-.12)

Male

.47

.98

.97

.24

.99

19.76 (28.40-13.75)

.54 (.70-.42)

Female

.57

.96

.95

.24

.99

13.55 (23.56-7.80)

.45 (.78-.25)

Male

.35

.99

.98

.43

.99

48.39 (83.77-27.95)

.66 (.80-.54)

Female

.28

.98

.96

.24

.98

13.55 (34.17-5.38)

.73 (.99-.54)

Male

.52

.96

.96

.18

.99

14.50 (19.94-10.54)

.50 (.66-.38)

Female

.54

.94

.93

.17

.99

8.82 (15.16-5.14)

.49 (.83-.29)

≥1

≥2

≥3

4

Avoidance item

Note. N = 6999 (Males = 5785, Females = 1214). PC-PTSD = Primary Care Posttraumatic Stress Disorder screen; PPV =
positive predictive value; NPV = negative predictive value; DLR+ = diagnostic likelihood ratio for a positive test; DLR- =
diagnostic likelihood ratio for a negative test; CI = confidence interval.
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the instrument in question than those without the disorder (Akobeng, 2006b). Since the PCPTSD screen is designed to detect probable PTSD, either of these examples would be
undesirable.
Cutoff ≥ 3 was the lowest cutoff level for which the DLR+ exceeded the threshold of 10
for both males and females (males: DLR+ = 19.76, 99% CI [28.40, 13.75]; females: DLR+ =
13.55, 99% CI [23.56, 7.80]), indicating that a respondent meeting this cutoff has a very strong
probability of actually having the disorder. Specifically, men later diagnosed with PTSD were
nearly 20 times more likely to answer three or more PC-PTSD items positively than men who
did not receive the diagnosis. Women who, subsequent to the screening, received a PTSD
diagnosis were over 13 times more likely to meet the three-item cutoff than women not so
diagnosed. The diagnostic efficiency achieved at this cutoff level (.97 for men, .95 for women)
was nearly as high as for the highest possible PC-PTSD scoring threshold of four positive items
(.98 for men, .96 for women).
The USAF cutoff ≥ 1 had the lowest DLR+ values (males: DLR+ = 7.56, 99% CI [8.77,
6.52]; females: DLR+ = 4.83, 99% CI [6.56, 3.56]). This means that the probability of a male
later identified with PTSD meeting the cutoff of 1 was about 7.5 times greater than for a male
not identified with the disorder. Diagnosed females were about five times more likely of the
same when compared to undiagnosed females. This cutoff exhibited the lowest specificity and
diagnostic efficiency values for both genders (women = .84 and men = .89 for both statistics).
However, this scoring configuration maximized sensitivity for both women (.78) and men (.85).

117
The single-item screen using only the avoidance question (males: DLR+ = 14.50, 99%
CI [19.94, 10.54]; females: DLR+ = 8.82, 99% CI [15.16, 5.14]) had higher DLR+ values than
either the cutoff of 1or the cutoff of 2 (males: DLR+ = 12.55, 99% CI [15.86, 9.94]; females:
DLR+ = 8.47, 99% CI [12.27, 5.85]). While the DLR+ values for recommended cutoff (≥ 3)
were higher than for the single-item screen, the sensitivity and specificity values were
comparable. The specificity of the single-item screen (males = .96, females = .94) was only
slightly lower than the specificity of the cutoff of 3 (males = .98, females = .96). Likewise, the
disparities between the sensitivity values for the single-item screen (men = .52, women = .54)
and those for the recommended cutoff (.47 and .57, respectively) were small. Efficiency for this
scoring regime (.96 for males, .93 for females) was higher than for a cutoff of 2 (.94 for men, .91
for women), but a little lower than for the ≥ 3 cutoff (.97 and .95, respectively). This was similar
to the result reported by Bliese and colleagues (2008).
Validity using CFA
The a priori model is illustrated in Figure 3. Two latent factors were included in the
model and were allowed to correlate. Factor 1 corresponded to PTSD and had all four PC-PTSD
items loading on it. Factor 2, depression, was measured by the 2-item PHQ. As mentioned in
the chapter on methods, the variance of both factors was set to 1 and each path weight was freely
estimated. The model fit results will be presented first, followed by the substantive results
relating to validity.
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PC‐PTSD item 1

PC‐PTSD item 2

Factor 1
PTSD

PC‐PTSD item 3

PC‐PTSD item 4

Factor 2
Depression

Depression
item 1
Depression
item 2

Figure 3. A priori CFA model for assessment of convergent and divergent validity in the PCPTSD. The depression items are from the 2-item PHQ.
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A Priori Model Fit
Nonzero paths. The first assessment of model fit involved testing whether each path
weight was significantly different from zero. As shown in Table 8, for each path weight in the a
priori model the ratio of the estimate divided by the estimate’s standard error was much larger
than 1.96—the threshold for significance with α = .05. The lowest value was 57.47 for the
arousal indicator of the PTSD factor. Also, none of the 95% CIs contained the value of zero.
Examination of model fit. The a priori model did not exhibit perfect fit with the data (χ2
= 159.91, 5 d.f., p < .001). Close fit was indicated by the CFI (.989) exceeding .95. The value of
the RMSEA (.067), on the other hand, was indicative of moderate fit.
The residual covariances were also inspected. All of the residuals were close to zero,
indicating good fit. However, the three values showing the greatest deviation from zero were for
PC-PTSD item 1 with PC-PTSD item 4 (-.095), PC-PTSD item 1 with the PHQ little interest
item (-.080), and PC-PTSD item 4 with the PHQ little interest item (.085).
Three modification index (MI) values exceeded the chosen minimum of 10 and were
therefore of concern. The largest (132.24) occurred for PC-PTSD item 4 (numbing) with Factor
2 (depression). The MIs for PC-PTSD item 1 (reexperiencing; MI = 30.99) and item 3 (arousal;
MI = 30.44) also suggested that the model fit would improve by making these items indicators of
Factor 2.
Specification of Model 2
Since the highest MI value suggested that allowing the PC-PTSD numbing indicator to
load on the depression factor would result in closer fit for the model, item 4 was examined more
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Table 8
A Priori Model: CFA of the PC-PTSD and 2-Item PHQ Screens
Estimates (SE)
Scale

PTSD

Depression

Est./SE

95% CI

Reexperiencing

.88 (.01)

--

73.83

[.86, .91]

Avoidance

.92 (.01)

--

86.50

[.90, .94]

Arousal

.82 (.01)

--

57.47

[.79, .84]

Numbing

.94 (.01)

--

90.43

[.92, .96]

Little interest

--

.93 (.01)

89.79

[.91, .95]

Feeling down

--

.93 (.01)

94.78

[.91, .95]

50.44

[.71, .76]

PC-PTSD

2-item PHQ

Correlated factors
PTSD-Depression
χ2

.74 (.02)
159.91 @ 5 d.f.***

CFI

.989

RMSEA

.067

Note. N = 6963 (Males = 5756, Females = 1207). PC-PTSD = Primary Care Posttraumatic Stress
Disorder screen; PHQ = Patient Health Questionnaire; SE = standard error; Est. = estimate; CI =
confidence interval; d.f. = degrees of freedom; CFI = comparative fit index; RMSEA = root mean square
error of approximation.
***p < .001.
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closely in an attempt to provide some insight into this result. This item reads, “Felt numb or
detached from others, activities, or your surroundings.” One of the two-item PHQ screen
questions reads, “Little interest or pleasure in doing things.” In fact, the DSM-IV (APA, 1994)
depression symptom from which this PHQ item was drawn elaborates to include little interest in
“activities.” The two queries appear to be covering—if not the same mood-related concept—at
least similar aspects of a related concept. For instance, if a subject were experiencing PTSD
symptoms and felt numb to people and/or activities to the degree that they endorsed item 4 on
the PC-PTSD, it would logically follow that the same respondent might also be expected to
endorse an item assessing whether they were having problems with lack of interest in “things,”
which might naturally include activities and social interaction. Thus, these items may have
additionally been serving as indicators of anhedonia, a well-recognized symptom of depression.
To test this hypothesis, a second CFA model was specified in a manner that would allow
a nested model comparison with the a priori model. For CFA model 2, item 4 was allowed to be
an indicator variable for both PTSD (Factor 1) and depression (Factor 2). The structure of model
2 is illustrated in Figure 4.
Model 2 Fit
Nonzero paths. Table 9 summarizes the results for model 2. As with the a priori model,
model 2 contained all nonzero paths. Evidence for this was found in the estimate to standard
error ratios which were all larger than 1.96 (the smallest was 12.42) and in the 95% CIs—none
of which were inclusive of zero.
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PC‐PTSD item 1

PC‐PTSD item 2

Factor 1
PTSD

PC‐PTSD item 3

PC‐PTSD item 4

Factor 2
Depression

Depression
item 1
Depression
item 2

Figure 4. Model 2: CFA model for assessment of convergent and divergent validity in the PCPTSD. PC-PTSD item 4 (numbing) is allowed to be an indicator for both the PTSD and
depression factors. The depression items are from the 2-item PHQ.

123
Table 9
Model 2: CFA of PC-PTSD and 2-Item PHQ Screens
Estimates (SE)
Scale

Est./SE

95% CI

PTSD

Dep.

PTSD

Dep.

PTSD

Dep.

Reexperiencing

.90 (.01)

--

75.04

--

[.87, .92]

--

Avoidance

.95 (.01)

--

88.60

--

[.93, .97]

--

Arousal

.84 (.02)

--

58.04

--

[.82, .87]

--

Numbing

.62 (.03)

.37 (.03)

21.73

12.42

[.56, .67]

[.31, .43]

Little interest

--

.92 (.01)

--

90.95

--

[.90, .94]

Feeling down

--

.93 (.01)

--

95.99

--

[.91, .95]

PC-PTSD

2-item PHQ

Correlated factors
PTSD-Depression
χ2

.66 (.02)

36.16

[.62, .70]

38.48 @ 5 d.f.***

CFI

.998

RMSEA

.031

Note. N = 6963 (Males = 5756, Females = 1207). Numbing is an indicator for both latent factors (PTSD,
depression). PC-PTSD = Primary Care Postraumatic Stress Disorder screen; PHQ = Patient Health
Questionnaire; Dep. = Depression; SE = standard error; Est. = estimate; CI = confidence interval; d.f. =
degrees of freedom; CFI = comparative fit index; RMSEA = root mean square error of approximation.
***p < .001.
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Examination of model fit. Imperfect fit with the data was again indicated (χ2 = 38.48, 5
d.f., p < .001). However, the CFI (.998) exceeded the .95 threshold for close fit and the RMSEA
(.031) suggested a good fit between the data and the specified model. The residuals for the
covariances were generally lower than for the a priori model, with deviation the greatest for PCPTSD item 3 with PC-PTSD item 2 (-.043) followed by PC-PTSD item 4 with PC-PTSD item 3
(.042) and the PHQ feeling down item with PC-PTSD item 2 (.039). One MI, for PC-PTSD item
2 (avoidance), exceeded the cutoff of 10 (10.70), suggesting that the model fit would improve if
this item were made a manifest variable for the depression factor. Since this MI was only
slightly above the threshold of 10 and there was no readily apparent theoretical justification for
allowing depression to load on the PC-PTSD avoidance item, no further model modifications
were specified.
Model Comparison
Due to estimator that Mplus uses with categorical variables in CFA, the model fit chisquare values reported previously for each model could not be used to directly calculate a chisquare difference. Instead, an extra analysis step was required which resulted in the output of a
chi-square difference that is appropriate for the estimator. In this case, the resulting chi-square
difference test (χ2 = 91.28, 1 d.f., p < .001) indicated that allowing both the PTSD and depression
factors to load on the numbing item improved the model fit to a statistically significant degree
when compared to the model that restricted numbing to being an exclusive indicator for PTSD.
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Validity Results
Convergent validity. For the a priori model, the estimated path weights for each
expected factor indicator were all very strong (≥ .60). In fact, the lowest estimate was for the
arousal indicator (PC-PTSD item 3) of Factor 1 (PTSD) at .82. The others all approached or
were above .90. Thus, it appears that the model demonstrated good convergent validity for the
PC-PTSD.
Likewise, for model 2 most path weights were above .60 and, therefore, strong. While
still judged as a “strong” path weight, numbing as an indicator of PTSD (.62) was the only PCPTSD item whose path weight was not estimated at .80 or above. With the PTSD factor loading
strongly on all four PC-PTSD items, model 2 provided further evidence of good convergent
validity for scores on the PC-PTSD screen.
Divergent validity. In the a priori model, the correlation between the latent factors was
somewhat high (.74). That the factors were highly correlated is, perhaps, not surprising given
the high comorbidity of depression with PTSD. However, the correlation was below .80,
indicating sufficient discriminant validity according to Brown (2006). This result appears to
provide evidence of divergent validity for the PC-PTSD, at least at the scale level. However, due
to the high MI for this model indicating better fit would be achieved by making numbing an
indicator for the depression factor, attention was turned to model 2 and the items within the PCPTSD scale.
As noted previously, allowing numbing to serve as an indicator for both latent factors in
model 2 resulted in a statistically significant improvement in model fit. The inter-factor
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correlation was further reduced to .66 in this model, again demonstrating scale-level divergent
validity for the PC-PTSD scores. Upon closer inspection, the lowest path weight value in model
2 was the path linking depression with the numbing item (.37). This was considered weak (<
.40). In contrast, not only were path weights linking PTSD to numbing (.62) and the other three
PC-PTSD items strong (one greater than .80 and two at least .90), but the path weights associated
with the two PHQ items as manifest variables for depression were also very high (both greater
than .90). This marked disparity in path weights in model 2 pointed toward good divergent
validity at the item-level for the PC-PTSD scores.
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CHAPTER V: DISCUSSION
The purpose of this dissertation was to examine whether the scores from the PC-PTSD
are equally valid for both male and female military veterans returning from combat. In this
population, the results were generally consistent with the current practice of interpreting the PCPTSD scores in the exact same manner for both genders. The large sample size and multiple
methodologies used in the current study lend confidence that, if there were bias in the
instrument, it very likely would have been detected. Several findings point to the lack of
differential validity by gender for the PC-PTSD.
Summary of Findings on Research Questions
Research Question 1
This research question specifically addressed measurement non-equivalence in the PCPTSD by gender. The IRT DIF results provided no evidence of differential functioning of the
items on the PC-PTSD for males and females. While for each item there were differences in
both the a and b parameters across the male and female respondent groups, none of these
differences were statistically significant. The finding of no DIF was especially striking given the
very large sample size which gave the analysis unusually high statistical power to detect DIF if it
had existed.
This result means that males and females with similar levels of the PTSD trait (denoted
by θ in the IRT model) will respond similarly to the PC-PTSD items. By implication, then, any
gender differences in the likelihood to respond “Yes” to some or all of the PC-PTSD items were
unlikely to be due to differential functioning within the items themselves. Rather, these results
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support the idea that it is more probable that gender disparities in the manifestation of underlying
PTSD are contributing to any observed response differences on this screening instrument. Some
of the potential sources of such PTSD gender differences—trauma exposure, neurophysiology,
and reactions to trauma—were discussed earlier in the literature review chapter.
Research Question 2
The second research question sought to determine whether the PC-PTSD showed
differential prediction of PTSD among males and females using various scoring configurations.
The cutoff levels of 1, 2, and 3 were assessed using both logistic regression interaction models
and comparison of male and female diagnostic likelihood ratios (DLRs). Under both analysis
regimes, there was no evidence to support differential prediction by gender. Likewise, no
significant differences in PTSD prediction were found between males and females when the PCPTSD total score was evaluated using logistic regression or when a cutoff of 4 was analyzed
using DLRs. This confirmation of the PC-PTSD’s validity was especially important because the
scoring regime used by the USAF, cutoff ≥ 1, does not appear to be biased toward identifying
higher rates of PTSD risk for either males or females.
Also, the results suggested that any gender differences in the rate at which the PC-PTSD
identifies risk for PTSD are not related to any differential prediction by PC-PTSD scores. For
example, although the PC-PTSD did identify a higher percentage of women than men as being at
risk for PTSD, the magnitude of the difference was similar to the observed differential in PTSD
prevalence by gender as judged by the clinical diagnosis criterion. Within the logistic
regression/diagnostic utility sample (N = 6999), at the recommended cut score of 3 the PC-PTSD
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identified 5.44% of women and 3.08% of men as being at risk of PTSD. The ratio of these rates
shows that females were 1.77 times as likely to be screened positive for risk of PTSD. The
sample prevalence of PTSD, as indicated by the clinical diagnosis criterion, was 2.31% for
females versus 1.54% for males. PTSD was, therefore, 1.5 times more prevalent in this sample
among females. Both gender differentials are comparable to those reported in the previously
discussed PTSD prevalence literature and are reasonably similar to one another. Again, it is
worth noting that, even with high levels of statistical power supplied by a relatively large sample
size and using two distinct methods of analysis, no statistically significant differential prediction
by gender was detected.
One DLR+ gender difference was, though not statistically significant, strikingly large.
For the cutoff level of 4, the male DLR+ (48.39, 99% CI [83.77, 27.95]) was more than three
times greater than the female DLR+ (13.55, 99% CI [34.17, 5.38]). There was also a great deal
of variation between the PPV for men and women (.43 and .24, respectively). It appears, though,
that relatively large 99% CIs prevented the DLR+ difference from being statistically significant.
The wide CIs likely resulted from the extremely low number of respondents that met the cutoff
of four (72/5785 men, 33/1214 women) and that were clinically diagnosed with PTSD (89/5785
men, 28/1214 women). The resulting cross tabulation cell for true positives had only 31 cases
for males (43.1% of those positive on the cutoff of 4) and 8 cases for females (24.2% of those
positive on the cutoff of 4). Since the small figures for both true and false positives are used in
the denominator of the DLR+ CI, the calculated intervals were relatively large.
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Research Question 3
This research question pertains to the predictive validity of the proposed one-item screen
for PTSD using only the avoidance item (item 3) from the PC-PTSD. As with the various
scoring configurations of the PC-PTSD in the discussion of the previous research question,
neither the logistic regression interaction analysis nor the DLR analysis yielded evidence that the
single-item screen differentially predicted PTSD between men and women. The implications
were likewise similar for the avoidance screen: Differences in the rate of males and females
identified as at risk for PTSD mirrored the observed differences between the genders in the
sample prevalence of PTSD.
The study also confirmed some of the findings from the initial study proposing the singleitem screen. Like Bliese et al. (2008), the diagnostic efficiencies of the avoidance-only screen
(.96 for males, .93 for females) fell roughly between those of the cutoff of 2 (.94 for males, .91
for females) and the cutoff of 3 (.97 and .95, respectively). Also, while only the one-item screen
male DLR+ rose above the threshold of 10, indicating a very high likelihood of diagnosis for
those screening positive (DLR+male = 14.50, DLR+female = 8.82), both DLR+ gender values were
higher than for both the ≥ 2 cutoff (DLR+male = 12.55, DLR+female = 8.47) and for the ≥ 1 cutoff
used by the USAF (DLR+male = 7.56, DLR+female = 4.83). The specificity of this reduced screen
(male = .96, female =.94) was almost as high as for the previously recommended ≥ 3 cutoff
(male = .98, female =.96). Finally, the sensitivities were similar between the avoidance-only
screen (.52 for men, .54 for women) and the ≥ 3 cutoff (.47 for men, .57 for women), but the
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single-item screen appeared to have the advantage of less variability in the sensitivities for the
male versus the female groups.
These results compared favorably to those of Bliese and colleagues (2008) on the
avoidance-only PC-PTSD screen, but with a much larger sample size of females (1214 in the
current study compared to 13 in the former). This analysis, therefore, extends support for the
viability of this reduced screen to female as well as male veterans.
Research Question 4
As Prins and colleagues (2003) noted, in their study the recommended cutoff of 3
positive PC-PTSD items resulted in markedly lower sensitivity and specificity values for females
when compared to males. The fourth research question was posed to determine whether similar
differences in diagnostic utility would hold within a military population returning from
deployment.
Generally, sensitivity exhibited greater variability than specificity across gender in this
sample (see Table 7). Any variability in specificity may have been muted by the
overwhelmingly large proportion of both negative PC-PTSD responses and negative PTSD
clinical diagnosis status for both genders. Since specificity is given by the true negatives divided
by all negative diagnosis results and the true negatives are those cases where both the test and
diagnosis are negative, it is logical that the ratio of true negatives to total diagnostic negatives
would be nearly one for both males and females in this study.
The scoring configuration with the largest sensitivity gender disparity occurred at the
cutoff level of 3 (.57 for women, .47 for men). This finding was the opposite of that in Prins et
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al. (2003) which reported lower sensitivity for women. The figures from this study are in a
similar range to the sensitivity of cutoff ≥ 3 found with Army members returning from Iraq (.46
for males and females, combined) in Bliese et al. (2004).
The sensitivity of the PC-PTSD was also found to be higher for females in this sample
using cutoff ≥ 2 (.75 for females, .68 for males) and avoidance-only (.54 for females, .52 for
males). This pattern was reversed, however, for the cutoff ≥ 1 (.78 for females, .85 for males)
and the cutoff of 4 (.28 for females, .35 for males). It is difficult to draw conclusions from the
highly variable direction of differences in sensitivity between males and females. Certainly, one
possible explanation, as was proposed in Prins et al. (2003) is that gender differences in
comorbid conditions may be a factor.
Also, while sensitivity and specificity are theoretically independent of condition
prevalence, these measures are influenced by factors such as the intensity of the index condition.
Greater intensity in the tested condition generally leads to better diagnostic accuracy for the
tested instrument (Zhou et al., 2002). So, gender differences in the intensity of PTSD or of
particular symptoms could be contributing to this variability. Since none of the datasets used for
this study contained information on the intensity of PTSD, it was impossible to control for this
variable. It may be, then, that unmeasured “spectrum of disease” (Zhou et al., 2002, p. 21)
gender differences, such as PTSD intensity, account for some of the variation between male and
female sensitivity and specificity values.
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Research Question 5
The final research question sought to examine evidence for convergent and divergent
validity of the PC-PTSD scores in a sizable population of military males and females returning
from combat deployments. Given that large-scale epidemiological research has shown that as
many as 48% of those experiencing PTSD will also be diagnosed with major depression during
their lifetime (Kessler et al., 1995), it was encouraging that the CFA analysis found evidence that
the PC-PTSD items showed adequate convergent and divergent validity when modeled with a
previously validated depression screen.
In both the a priori model and model 2, convergent validity was indicated by the strong
path weights connecting the PTSD factor and the PC-PTSD items. Similarly, for each model the
correlation between the latent factors (PTSD and depression) was sufficiently low to provide
evidence of scale-level divergent validity for PC-PTSD scores. Item-level divergent validity was
demonstrated in both models, as well: When the PC-PTSD numbing item was freed to indicate
either PTSD or depression, the path weight associated with depression was weak while the PTSD
path weight was strong (as were all other paths linking PTSD and PC-PTSD items). On balance,
the findings from each of the planned analyses bolstered the construct validity of the PC-PTSD
scores with a sample of returning military combat deployers.
Other Findings
Cutoff ≥ 1 appears to have provided the best balance between high sensitivity and high
specificity in this sample of the PDHRA target population (sens. = .85 for males, .78 for females;
spec. = .89 for males and .84 for females). As stated in a policy memorandum from the Office of
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the USAF Surgeon General (2005, December 8), the purpose of the USAF PDHRA program is
to identify potential deployment-related health problems “proactively” (Office of the USAF
Surgeon General, 2005, December 8, p. 1) so as to facilitate early treatment. The emphasis is on
identifying as many people as possible that are potentially suffering from PTSD symptoms in
order to get them appropriate assistance sooner than later.
Therefore, it is important to maximize sensitivity in the PC-PTSD screen, because, as
mentioned previously, higher sensitivity results in a lower rate of false negatives. In the present
case, false negatives are those respondents who actually have a problem with PTSD but were not
flagged by the screening method as such. Failure to refer an individual who, in reality, is at-risk
for PTSD limits that individual’s opportunity for early, appropriate care. A drawback, though, of
choosing the cutoff of one is that it results in lower specificity than for the other PC-PTSD
scoring configurations. However, it does not seem that a false positive rate (given by 1 –
specificity) of 11-16% (for men and women, respectively) would overburden the military
medical or mental health systems.
Limitations of the Study
Despite the various findings from this study that lend support to the validity of the PCPTSD across gender groups, the conclusions drawn must be tempered by a number of
limitations. First of all, while the main sample constituted the entire population of male and
female USAF members who had returned from deployment to Iraq and Afghanistan and who had
completed all PC-PTSD items during 2008 and 2009 within 90 to 180 days of their return, this
sample did not constitute a random sample of any larger population (such as all returning
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military deployers or military veterans-at-large) and so may not be generalizable beyond the
study population. Also, as mentioned in the results section, excluding cases without a military
medical visit 90 days after the screening resulted in the elimination of nearly all subjects who
were either members of the national guard or reserve in both the logistic regression/diagnostic
utility sample and the CFA sample. Consequently, the results of the predictive validity and CFA
portions of the study may only be generalizable to active duty USAF military deployers and not
to national guard members or reservists.
Another sample-related issue is that, with the available data, it is impossible to know why
non-responders failed to respond. Since participation in the PDHRA is not required, some
number of returning USAF deployers undoubtedly elected not to even log into the online
screening instrument. However, no information is available regarding those who were offered
the PDHRA but declined to participate. Others who did register some level of participation in
the larger PDHRA did not respond to one or more PC-PTSD items. Such subjects were excluded
from the analysis. In the case of either type of non-response, if there was a systematic reason for
not responding the study sample would be less representative of the target population and the
study results would be less generalizable due to the resulting bias. Such bias cannot be ruled out
due to the lack of data regarding the reasons for any lack of response. However, as noted in the
method section, the percentage of cases deleted because of missing data was very small and it is
unlikely that any possible systematic differences between responders and non-responders would
have much of an effect on the results given the substantial sample size. Also, there was no
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statistically significant relationship between gender and case deletion due to missing response
data in any of the three study samples.
The primary analysis in this study was to assess measurement equivalence across gender
for the PC-PTSD items. However, use of the 2PL IRT model with these data resulted in lack of
item-fit for two of the four items. M. O. Edelen stated in personal communication (April 26,
2010) that such lack of fit is not uncommon when an instrument yields very few positive
responses upon use with the tested population. Indeed, very sparse positive responses were a
characteristic of the data from this study sample. Dr. Edelen suggested that it might be helpful to
identify a subsample of the original sample with a much higher proportion of positive responses
on the PC-PTSD items by identifying a PTSD risk factor, such as the presence of depression.
However, it was unclear how to proceed with this recommendation within the current
study. First of all, it would appear that higher rates of exposure to combat, which is assumed to
be the case with this sample of returning Iraq and Afghanistan veterans (Smith et al., 2008),
would already constitute a major risk factor for PTSD. Second, the number of cases identified
clinically as having a depression diagnosis was so small that using this criterion to determine
inclusion in a higher-PTSD risk subsample would result in at least one of the comparison group
sample sizes falling markedly below the suggested minimum of 500 for meaningful IRT
parameterization (Reise & Yu, 1990).
Another potential limitation related to the IRT DIF methods employed in this study is that
the anchor items are assumed to be free of any DIF. While the preliminary anchor identification
analyses using regression and graphical means found that items 3 and 4 appeared to exhibit
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relatively less potential DIF, the potential DIF was not zero. Items 3 and 4 were chosen as
anchors because they exhibited the lowest standardized residual values for the b and a
parameters, respectively. However, the residuals for parameter a on the third item and for
parameter b on the fourth item were relatively high. In fact, the item 3 residuals on the a
parameter were the second highest out of all four items—higher than the a residuals on item 2,
which was one of the suspected DIF items. Similarly, the b residuals associated with item 4
were nearly as high as those for item 1—the other suspected DIF item. This means that the
model comparison method likely was only able to detect any DIF above and beyond that already
present in the anchor criterion. The net result may have been attenuated ability of the likelihood
ratio test to detect DIF in these items with this sample.
The need to identify DIF-free anchors would appear to constitute a weakness of using
IRT DIF methods with an instrument constructed using so few items. It stands to reason that if
there had been many more items, the likelihood of finding at least one anchor item with
negligible, or at least very low, residuals on both parameters would have been greater. Also, the
chosen anchoring method resulted in only two of the items (1 and 2) being analyzed for DIF
using IRT modeling.
As was mentioned in the chapter on methods, it was less than ideal to use a clinical
diagnosis as the criterion in the predictive validity analyses. Studies that had compared the
performance of a clinical PTSD diagnosis to a structured interview (MacGruder et al., 2005;
Prins et al., 2003) have revealed low sensitivity for the clinical assessment. If one takes the
highest value for sensitivity between the studies, .61, that works out to a 39% false negative rate.
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The sample for the present study was skewed strongly toward negative diagnosis status. A
diagnostic criterion with better diagnostic utility may have reduced this skew somewhat and
would certainly have provided a more accurate assessment of the predictive validity of the PCPTSD scores.
Another limitation involved a form of the history effect. In this sense, history is defined
as an event or circumstance, other than the IV(s), that is contemporary with the study and affects
the DV (Schutt, 2006). Due to the time lapse (varying from 0 to 90 days for each respondent)
from the screening to the clinical encounter, it is impossible to know whether the screen and the
subsequent clinical evaluation were measuring PTSD symptoms related to the same potentially
traumatizing event(s). Specifically, some other trauma-inducing event (sexual assault, MVA,
etc.) could have occurred to a respondent after returning from deployment and participating in
the PDHRA but prior to being medically evaluated. Likewise, these data provided no way to
know whether such events occurred differently for men and women in some systematic way.
For example, men have been shown to more frequently experience potentially
traumatizing events when compared to women (Kessler et al., 1995; Norris et al., 2003). If in the
present study men more often experienced a trauma during the interim between screening and
diagnosis, this might tend to increase any related PTSD symptoms and increase the likelihood
that those males would receive a PTSD diagnosis. The current study was not able to account for
this history effect and it is unclear what, if any, influence may have resulted on the observed
predictive validity results for the PC-PTSD across males and females.
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Finally, this study lacked any measures of PTSD intensity. The use of mostly
dichotomous measures largely precluded this level of detail in condition analysis. Consequently,
it is difficult to rule out this important disease spectrum factor as possibly contributing to gender
differences in diagnostic accuracy values.
Conclusions and Recommendations
Despite the noted limitations, this dissertation makes significant contributions to
knowledge about PTSD screening in a military population. First, the PC-PTSD exhibited no
significant gender DIF when assessed using IRT methods. Second, the predictive validity of this
instrument was shown to be consistent across both males and females. Third, previous results
regarding the validity of a potential single-item PTSD screen were confirmed. Fourth, the PCPTSD demonstrated good evidence supporting convergent and divergent validity when modeled
with a highly comorbid condition. Finally, the USAF scoring regime for the PC-PTSD was also
confirmed as valid. Importantly, each of these findings occurred within the context of good
statistical power due to a large sample of returning military deployers that also contained a
substantial number of women. This study extends the body of research confirming that the PCPTSD shows robust characteristics that recommend it for continued use as a primary method for
early identification of PTSD among military veterans—both male and female.
Future work remains to be done to ensure the measurement equivalence of the PC-PTSD
across gender. Given the problems that arose in this study related to anchor items and model fit,
CFA group difference methods could, perhaps, provide an alternative to IRT DIF methods that
would not require anchoring (Byrne, 2001). Additionally, CFA model fit can be evaluated using
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a wider range of indices than are available for IRT modeling (Reise et al., 1993). Future
analyses should also focus on measurement equivalence across groups subdivided along
characteristics other than gender, such as ethnicity and age.
The current study focused on the PC-PTSD, which has four items which approximate
each of the PTSD symptom clusters as they are conceptualized in the four-cluster model
(Asmundson et al., 2004). More insight could be gained into any gender bias within specific
PTSD symptoms by conducting measurement equivalence studies across gender for instruments
that contain a specific query for each of the seventeen PTSD symptoms. Such instruments
include the PCL (Blanchard et al., 1996; Weathers et al., 1993) and the Modified PTSD
Symptom Scale—Self-Report (MPSS; Falsetti, Resnick, Resick, & Kilpatrick, 1993).
While this study provided initial confidence for consistent prediction of PTSD by the
scores on the PC-PTSD when used with male and female veterans, the research would have
benefited from using a PTSD criterion that was more reliable than a clinical diagnosis. Future
validity work related to PC-PTSD should, whenever feasible, use a structured clinical interview
as the gold standard indicating presence or absence of PTSD. Both the CAPS (Blake et al.,
1995) and the Composite International Diagnostic Interview (CIDI; World Health Organization,
1997) have demonstrated high reliability and, specifically, good diagnostic utility with PTSD.
Although the CAPS was designed for use by clinical professionals, both the CAPS and the CIDI
can be administered by paraprofessionals with adequate training (Cusack et al., 2002). Thus, it
could be practical to use these structured interviews to assess relatively large numbers of men
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and women to test for differential prediction across gender with greater reliability than was
possible in the current design.
It will also be important to attempt to control for the intensity of the PTSD condition
being tested. Chung and Breslau (2008) provided an example of how PTSD disturbance level
might serve as a proxy for condition severity. By controlling for severity researchers may gain
insight into any remaining variability in the diagnostic accuracy of instruments such as the PCPTSD between males and females.
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